KR20060009916A - 아릴 알킬 산 유도체의 제조 및 비만증을 치료하기 위한그의 용도 - Google Patents

Info

Publication number

KR20060009916A

KR20060009916A KR1020057021232A KR20057021232A KR20060009916A KR 20060009916 A KR20060009916 A KR 20060009916A KR 1020057021232 A KR1020057021232 A KR 1020057021232A KR 20057021232 A KR20057021232 A KR 20057021232A KR 20060009916 A KR20060009916 A KR 20060009916A

Authority

KR

South Korea

Prior art keywords

biphenyl

amino

carbonyl

trans

benzothiazol

Prior art date

2003-05-09

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Ceased

Links

• Espacenet
• Global Dossier
• Discuss

• 239000002253 acid Substances 0.000 title claims abstract description 39
• 208000008589 Obesity Diseases 0.000 title claims abstract description 35
• 235000020824 obesity Nutrition 0.000 title claims abstract description 34
• 125000003710 aryl alkyl group Chemical group 0.000 title abstract description 5
• 238000002360 preparation method Methods 0.000 title description 26
• 150000001875 compounds Chemical class 0.000 claims abstract description 209
• 239000000203 mixture Substances 0.000 claims abstract description 203
• 238000000034 method Methods 0.000 claims abstract description 101
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 22
• -1 1-piperidinylcarbonyl Chemical group 0.000 claims description 139
• 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 79
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 60
• JBDSSBMEKXHSJF-UHFFFAOYSA-N cyclopentanecarboxylic acid Chemical compound OC(=O)C1CCCC1 JBDSSBMEKXHSJF-UHFFFAOYSA-N 0.000 claims description 45
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 38
• 150000002148 esters Chemical class 0.000 claims description 35
• 239000003814 drug Substances 0.000 claims description 31
• 229910052739 hydrogen Inorganic materials 0.000 claims description 30
• 239000001257 hydrogen Substances 0.000 claims description 29
• 125000001424 substituent group Chemical group 0.000 claims description 29
• 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 28
• 239000008194 pharmaceutical composition Substances 0.000 claims description 28
• 238000011282 treatment Methods 0.000 claims description 26
• 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 23
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 22
• 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 22
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 22
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 22
• 150000003839 salts Chemical class 0.000 claims description 20
• 125000004432 carbon atom Chemical group C* 0.000 claims description 18
• 235000014113 dietary fatty acids Nutrition 0.000 claims description 18
• 229930195729 fatty acid Natural products 0.000 claims description 18
• 239000000194 fatty acid Substances 0.000 claims description 18
• 239000003112 inhibitor Substances 0.000 claims description 18
• 229910052799 carbon Inorganic materials 0.000 claims description 16
• 229940079593 drug Drugs 0.000 claims description 16
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 16
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 16
• 238000009472 formulation Methods 0.000 claims description 14
• 208000035475 disorder Diseases 0.000 claims description 13
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 13
• 125000004093 cyano group Chemical group *C#N 0.000 claims description 12
• 150000004665 fatty acids Chemical class 0.000 claims description 12
• 125000004750 (C1-C6) alkylaminosulfonyl group Chemical group 0.000 claims description 11
• 125000004845 (C1-C6) alkylsulfonylamino group Chemical group 0.000 claims description 11
• 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims description 11
• 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims description 11
• 125000003806 alkyl carbonyl amino group Chemical group 0.000 claims description 11
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 10
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 9
• 239000002585 base Substances 0.000 claims description 9
• 239000003153 chemical reaction reagent Substances 0.000 claims description 9
• 239000003795 chemical substances by application Substances 0.000 claims description 9
• 239000003937 drug carrier Substances 0.000 claims description 9
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 8
• BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 8
• NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 claims description 8
• 206010012601 diabetes mellitus Diseases 0.000 claims description 8
• 150000002431 hydrogen Chemical class 0.000 claims description 8
• 229910052717 sulfur Inorganic materials 0.000 claims description 8
• DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical class C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 claims description 7
• 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 claims description 7
• 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 claims description 7
• LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 7
• RPGOKSGWOZBYFF-UHFFFAOYSA-N 4-[4-[4-(1,3-benzothiazol-2-ylamino)phenyl]phenyl]-2,2-dimethyl-4-oxobutanoic acid Chemical compound C1=CC(C(=O)CC(C)(C)C(O)=O)=CC=C1C(C=C1)=CC=C1NC1=NC2=CC=CC=C2S1 RPGOKSGWOZBYFF-UHFFFAOYSA-N 0.000 claims description 6
• 239000003446 ligand Substances 0.000 claims description 6
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
• 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 claims description 5
• 102000004877 Insulin Human genes 0.000 claims description 5
• 108090001061 Insulin Proteins 0.000 claims description 5
• PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 5
• 102100040918 Pro-glucagon Human genes 0.000 claims description 5
• 239000000556 agonist Substances 0.000 claims description 5
• 208000029078 coronary artery disease Diseases 0.000 claims description 5
• VZFUCHSFHOYXIS-UHFFFAOYSA-N cycloheptane carboxylic acid Natural products OC(=O)C1CCCCCC1 VZFUCHSFHOYXIS-UHFFFAOYSA-N 0.000 claims description 5
• 229940125396 insulin Drugs 0.000 claims description 5
• 238000004519 manufacturing process Methods 0.000 claims description 5
• 229910000027 potassium carbonate Inorganic materials 0.000 claims description 5
• 230000004580 weight loss Effects 0.000 claims description 5
• 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 4
• 125000001054 5 membered carbocyclic group Chemical group 0.000 claims description 4
• 125000001960 7 membered carbocyclic group Chemical group 0.000 claims description 4
• 239000005541 ACE inhibitor Substances 0.000 claims description 4
• 206010020772 Hypertension Diseases 0.000 claims description 4
• 229940100389 Sulfonylurea Drugs 0.000 claims description 4
• 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 claims description 4
• 229910052794 bromium Inorganic materials 0.000 claims description 4
• 229910052760 oxygen Inorganic materials 0.000 claims description 4
• 229910052763 palladium Inorganic materials 0.000 claims description 4
• UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 4
• AOHBCGJOPIUWAT-DHIUTWEWSA-N (1r,2r)-2-[4-[4-[(5-methyl-1,3-benzoxazol-2-yl)amino]phenyl]benzoyl]cyclohexane-1-carboxylic acid Chemical compound N=1C2=CC(C)=CC=C2OC=1NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)[C@@H]1CCCC[C@H]1C(O)=O AOHBCGJOPIUWAT-DHIUTWEWSA-N 0.000 claims description 3
• VSUCJAJIHMRYAK-UHFFFAOYSA-N 2,2-dimethyl-4-[4-[4-[(4-methyl-1,3-benzoxazol-2-yl)amino]phenyl]phenyl]-4-oxobutanoic acid Chemical compound N=1C=2C(C)=CC=CC=2OC=1NC(C=C1)=CC=C1C1=CC=C(C(=O)CC(C)(C)C(O)=O)C=C1 VSUCJAJIHMRYAK-UHFFFAOYSA-N 0.000 claims description 3
• QDWOUASZOVXFQG-UHFFFAOYSA-N 2,2-dimethyl-4-[4-[4-[(6-methyl-1,3-benzoxazol-2-yl)amino]phenyl]phenyl]-4-oxobutanoic acid Chemical compound O1C2=CC(C)=CC=C2N=C1NC(C=C1)=CC=C1C1=CC=C(C(=O)CC(C)(C)C(O)=O)C=C1 QDWOUASZOVXFQG-UHFFFAOYSA-N 0.000 claims description 3
• KWMRHYQFTOZULH-UHFFFAOYSA-N 2-ethyl-4-phenylbutanoic acid Chemical compound CCC(C(O)=O)CCC1=CC=CC=C1 KWMRHYQFTOZULH-UHFFFAOYSA-N 0.000 claims description 3
• ILPUOPPYSQEBNJ-UHFFFAOYSA-N 2-methyl-2-phenoxypropanoic acid Chemical class OC(=O)C(C)(C)OC1=CC=CC=C1 ILPUOPPYSQEBNJ-UHFFFAOYSA-N 0.000 claims description 3
• 229940077274 Alpha glucosidase inhibitor Drugs 0.000 claims description 3
• 201000001320 Atherosclerosis Diseases 0.000 claims description 3
• 208000032928 Dyslipidaemia Diseases 0.000 claims description 3
• 108010004460 Gastric Inhibitory Polypeptide Chemical class 0.000 claims description 3
• 208000031226 Hyperlipidaemia Diseases 0.000 claims description 3
• 208000017170 Lipid metabolism disease Diseases 0.000 claims description 3
• 206010028980 Neoplasm Diseases 0.000 claims description 3
• 108010004684 Pituitary adenylate cyclase-activating polypeptide Proteins 0.000 claims description 3
• 102000002808 Pituitary adenylate cyclase-activating polypeptide Human genes 0.000 claims description 3
• 239000003888 alpha glucosidase inhibitor Substances 0.000 claims description 3
• 239000000883 anti-obesity agent Substances 0.000 claims description 3
• 239000002220 antihypertensive agent Substances 0.000 claims description 3
• 239000003054 catalyst Substances 0.000 claims description 3
• 238000005859 coupling reaction Methods 0.000 claims description 3
• 229940125753 fibrate Drugs 0.000 claims description 3
• 150000002632 lipids Chemical class 0.000 claims description 3
• 239000011664 nicotinic acid Substances 0.000 claims description 3
• 235000001968 nicotinic acid Nutrition 0.000 claims description 3
• OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 claims description 3
• YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 claims description 3
• 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 3
• 230000004584 weight gain Effects 0.000 claims description 3
• 235000019786 weight gain Nutrition 0.000 claims description 3
• MQTBNDWDKDXDBV-WOJBJXKFSA-N (1r,2r)-2-[4-[4-[(4,6-difluoro-1,3-benzothiazol-2-yl)amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC[C@H]1C(=O)C1=CC=C(C=2C=CC(NC=3SC4=CC(F)=CC(F)=C4N=3)=CC=2)C=C1 MQTBNDWDKDXDBV-WOJBJXKFSA-N 0.000 claims description 2
• VZOWCNYXALKHKB-RTBURBONSA-N (1r,2r)-2-[4-[4-[(5,6-difluoro-1h-benzimidazol-2-yl)amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC[C@H]1C(=O)C1=CC=C(C=2C=CC(NC=3NC4=CC(F)=C(F)C=C4N=3)=CC=2)C=C1 VZOWCNYXALKHKB-RTBURBONSA-N 0.000 claims description 2
• IKJTYZKQVKNTNB-WOJBJXKFSA-N (1r,2r)-2-[4-[4-[(5,7-difluoro-1,3-benzothiazol-2-yl)amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC[C@H]1C(=O)C1=CC=C(C=2C=CC(NC=3SC4=C(F)C=C(F)C=C4N=3)=CC=2)C=C1 IKJTYZKQVKNTNB-WOJBJXKFSA-N 0.000 claims description 2
• MJBRPUOTBWGMFL-UHFFFAOYSA-N 2,2-dimethyl-4-[4-[4-[(5-nitro-1,3-thiazol-2-yl)amino]phenyl]phenyl]-4-oxobutanoic acid Chemical compound C1=CC(C(=O)CC(C)(C)C(O)=O)=CC=C1C(C=C1)=CC=C1NC1=NC=C([N+]([O-])=O)S1 MJBRPUOTBWGMFL-UHFFFAOYSA-N 0.000 claims description 2
• LZPWAYBEOJRFAX-UHFFFAOYSA-N 4,4,5,5-tetramethyl-1,3,2$l^{2}-dioxaborolane Chemical group CC1(C)O[B]OC1(C)C LZPWAYBEOJRFAX-UHFFFAOYSA-N 0.000 claims description 2
• YLGAFTJYZIGGKP-UHFFFAOYSA-N 4-[4-[4-(1,3-benzothiazol-2-ylamino)phenyl]phenyl]-2-(2-methoxyethyl)-4-oxobutanoic acid Chemical compound C1=CC(C(=O)CC(CCOC)C(O)=O)=CC=C1C(C=C1)=CC=C1NC1=NC2=CC=CC=C2S1 YLGAFTJYZIGGKP-UHFFFAOYSA-N 0.000 claims description 2
• MOYFZIZGYGZWJT-UHFFFAOYSA-N 4-[4-[4-(1,3-benzoxazol-2-ylamino)phenyl]phenyl]-4-oxo-2-(2-phenylethyl)butanoic acid Chemical compound C=1C=C(C=2C=CC(NC=3OC4=CC=CC=C4N=3)=CC=2)C=CC=1C(=O)CC(C(=O)O)CCC1=CC=CC=C1 MOYFZIZGYGZWJT-UHFFFAOYSA-N 0.000 claims description 2
• PDPGARTYIRCWIG-UHFFFAOYSA-N 4-[4-[4-[(6-chloro-1,3-benzothiazol-2-yl)amino]phenyl]phenyl]-2-[2-(dimethylamino)ethyl]-4-oxobutanoic acid Chemical compound C1=CC(C(=O)CC(CCN(C)C)C(O)=O)=CC=C1C(C=C1)=CC=C1NC1=NC2=CC=C(Cl)C=C2S1 PDPGARTYIRCWIG-UHFFFAOYSA-N 0.000 claims description 2
• AMURDOJAXFUVBG-UHFFFAOYSA-N 4-[4-[4-[[4-(4-chlorophenyl)-1,3-thiazol-2-yl]amino]phenyl]phenyl]-2,2-dimethyl-4-oxobutanoic acid Chemical compound C1=CC(C(=O)CC(C)(C)C(O)=O)=CC=C1C(C=C1)=CC=C1NC1=NC(C=2C=CC(Cl)=CC=2)=CS1 AMURDOJAXFUVBG-UHFFFAOYSA-N 0.000 claims description 2
• 229940123208 Biguanide Drugs 0.000 claims description 2
• 229940124802 CB1 antagonist Drugs 0.000 claims description 2
• 229940127291 Calcium channel antagonist Drugs 0.000 claims description 2
• 208000024172 Cardiovascular disease Diseases 0.000 claims description 2
• 208000005171 Dysmenorrhea Diseases 0.000 claims description 2
• 206010013935 Dysmenorrhoea Diseases 0.000 claims description 2
• 201000005569 Gout Diseases 0.000 claims description 2
• 208000035150 Hypercholesterolemia Diseases 0.000 claims description 2
• 229940127470 Lipase Inhibitors Drugs 0.000 claims description 2
• 108090000189 Neuropeptides Proteins 0.000 claims description 2
• 102000003797 Neuropeptides Human genes 0.000 claims description 2
• 208000018262 Peripheral vascular disease Diseases 0.000 claims description 2
• 206010036049 Polycystic ovaries Diseases 0.000 claims description 2
• 102100037505 Secretin Human genes 0.000 claims description 2
• 108010086019 Secretin Proteins 0.000 claims description 2
• 208000006011 Stroke Diseases 0.000 claims description 2
• 239000002333 angiotensin II receptor antagonist Substances 0.000 claims description 2
• 229940030600 antihypertensive agent Drugs 0.000 claims description 2
• 229940125710 antiobesity agent Drugs 0.000 claims description 2
• 239000002830 appetite depressant Substances 0.000 claims description 2
• 239000002876 beta blocker Substances 0.000 claims description 2
• 229940097320 beta blocking agent Drugs 0.000 claims description 2
• 239000003613 bile acid Substances 0.000 claims description 2
• 239000000480 calcium channel blocker Substances 0.000 claims description 2
• 201000011510 cancer Diseases 0.000 claims description 2
• 208000026106 cerebrovascular disease Diseases 0.000 claims description 2
• 229910052801 chlorine Inorganic materials 0.000 claims description 2
• 201000001883 cholelithiasis Diseases 0.000 claims description 2
• 230000008878 coupling Effects 0.000 claims description 2
• 238000010168 coupling process Methods 0.000 claims description 2
• 239000002934 diuretic Substances 0.000 claims description 2
• 229940030606 diuretics Drugs 0.000 claims description 2
• 208000020694 gallbladder disease Diseases 0.000 claims description 2
• 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
• 208000006575 hypertriglyceridemia Diseases 0.000 claims description 2
• 230000001939 inductive effect Effects 0.000 claims description 2
• 208000000509 infertility Diseases 0.000 claims description 2
• 230000036512 infertility Effects 0.000 claims description 2
• 231100000535 infertility Toxicity 0.000 claims description 2
• 229910052740 iodine Inorganic materials 0.000 claims description 2
• 230000003228 microsomal effect Effects 0.000 claims description 2
• 229960003512 nicotinic acid Drugs 0.000 claims description 2
• 201000008482 osteoarthritis Diseases 0.000 claims description 2
• 201000010065 polycystic ovary syndrome Diseases 0.000 claims description 2
• 239000002464 receptor antagonist Substances 0.000 claims description 2
• 229940044551 receptor antagonist Drugs 0.000 claims description 2
• 239000002461 renin inhibitor Substances 0.000 claims description 2
• 229940086526 renin-inhibitors Drugs 0.000 claims description 2
• 229960002101 secretin Drugs 0.000 claims description 2
• 239000003352 sequestering agent Substances 0.000 claims description 2
• 201000002859 sleep apnea Diseases 0.000 claims description 2
• 208000011580 syndromic disease Diseases 0.000 claims description 2
• 125000001475 halogen functional group Chemical group 0.000 claims 18
• 125000004356 hydroxy functional group Chemical group O* 0.000 claims 3
• YMGUBTXCNDTFJI-UHFFFAOYSA-N cyclopropanecarboxylic acid Chemical compound OC(=O)C1CC1 YMGUBTXCNDTFJI-UHFFFAOYSA-N 0.000 claims 2
• 239000008177 pharmaceutical agent Substances 0.000 claims 2
• 238000011321 prophylaxis Methods 0.000 claims 2
• WOQFPHQYISJISP-WOJBJXKFSA-N (1r,2r)-2-[4-[3-fluoro-4-[(6-methoxy-1,3-benzoxazol-2-yl)amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound O1C2=CC(OC)=CC=C2N=C1NC(C(=C1)F)=CC=C1C(C=C1)=CC=C1C(=O)[C@@H]1CCC[C@H]1C(O)=O WOQFPHQYISJISP-WOJBJXKFSA-N 0.000 claims 1
• HNYZRHJTAOKODH-RTBURBONSA-N (1r,2r)-2-[4-[3-fluoro-4-[[6-(trifluoromethyl)-1,3-benzothiazol-2-yl]amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC[C@H]1C(=O)C1=CC=C(C=2C=C(F)C(NC=3SC4=CC(=CC=C4N=3)C(F)(F)F)=CC=2)C=C1 HNYZRHJTAOKODH-RTBURBONSA-N 0.000 claims 1
• LOHFGECVJXRXMR-WOJBJXKFSA-N (1r,2r)-2-[4-[4-(1,3-benzothiazol-2-ylamino)phenyl]benzoyl]cyclobutane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CC[C@H]1C(=O)C1=CC=C(C=2C=CC(NC=3SC4=CC=CC=C4N=3)=CC=2)C=C1 LOHFGECVJXRXMR-WOJBJXKFSA-N 0.000 claims 1
• GTTCDQBVIYYEQE-NHCUHLMSSA-N (1r,2r)-2-[4-[4-(1,3-benzothiazol-2-ylamino)phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC[C@H]1C(=O)C1=CC=C(C=2C=CC(NC=3SC4=CC=CC=C4N=3)=CC=2)C=C1 GTTCDQBVIYYEQE-NHCUHLMSSA-N 0.000 claims 1
• JJAALGMOWHXNSJ-RTBURBONSA-N (1r,2r)-2-[4-[4-(1,3-benzothiazol-2-ylamino)phenyl]benzoyl]cyclopropane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1C[C@H]1C(=O)C1=CC=C(C=2C=CC(NC=3SC4=CC=CC=C4N=3)=CC=2)C=C1 JJAALGMOWHXNSJ-RTBURBONSA-N 0.000 claims 1
• RPPAOAPFKYSPEC-NHCUHLMSSA-N (1r,2r)-2-[4-[4-(1,3-benzoxazol-2-ylamino)phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC[C@H]1C(=O)C1=CC=C(C=2C=CC(NC=3OC4=CC=CC=C4N=3)=CC=2)C=C1 RPPAOAPFKYSPEC-NHCUHLMSSA-N 0.000 claims 1
• JBRHHXXUUWWMLT-NHCUHLMSSA-N (1r,2r)-2-[4-[4-(1h-benzimidazol-2-ylamino)phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC[C@H]1C(=O)C1=CC=C(C=2C=CC(NC=3NC4=CC=CC=C4N=3)=CC=2)C=C1 JBRHHXXUUWWMLT-NHCUHLMSSA-N 0.000 claims 1
• ZGRIRSYJGHEZPA-QZTJIDSGSA-N (1r,2r)-2-[4-[4-[(4,6-difluoro-1,3-benzothiazol-2-yl)amino]phenyl]benzoyl]cyclopropane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1C[C@H]1C(=O)C1=CC=C(C=2C=CC(NC=3SC4=CC(F)=CC(F)=C4N=3)=CC=2)C=C1 ZGRIRSYJGHEZPA-QZTJIDSGSA-N 0.000 claims 1
• NXEXOGHUXKSPKY-DHIUTWEWSA-N (1r,2r)-2-[4-[4-[(5,6-dimethyl-1,3-benzothiazol-2-yl)amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound S1C=2C=C(C)C(C)=CC=2N=C1NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)[C@@H]1CCC[C@H]1C(O)=O NXEXOGHUXKSPKY-DHIUTWEWSA-N 0.000 claims 1
• GVIVCRISHRFJKX-QZTJIDSGSA-N (1r,2r)-2-[4-[4-[(5,7-difluoro-1,3-benzothiazol-2-yl)amino]phenyl]benzoyl]cyclopropane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1C[C@H]1C(=O)C1=CC=C(C=2C=CC(NC=3SC4=C(F)C=C(F)C=C4N=3)=CC=2)C=C1 GVIVCRISHRFJKX-QZTJIDSGSA-N 0.000 claims 1
• RZUFJINKBGSBBW-DHIUTWEWSA-N (1r,2r)-2-[4-[4-[(5,7-dimethyl-1,3-benzothiazol-2-yl)amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound N=1C2=CC(C)=CC(C)=C2SC=1NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)[C@@H]1CCC[C@H]1C(O)=O RZUFJINKBGSBBW-DHIUTWEWSA-N 0.000 claims 1
• YOZJJRCGKFYMSR-FGZHOGPDSA-N (1r,2r)-2-[4-[4-[(5-methyl-1,3-benzoxazol-2-yl)amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound N=1C2=CC(C)=CC=C2OC=1NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)[C@@H]1CCC[C@H]1C(O)=O YOZJJRCGKFYMSR-FGZHOGPDSA-N 0.000 claims 1
• HITYXDZJGZIFET-RTBURBONSA-N (1r,2r)-2-[4-[4-[(6-chloro-1,3-benzothiazol-2-yl)amino]-3-fluorophenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC[C@H]1C(=O)C1=CC=C(C=2C=C(F)C(NC=3SC4=CC(Cl)=CC=C4N=3)=CC=2)C=C1 HITYXDZJGZIFET-RTBURBONSA-N 0.000 claims 1
• HGLSWTPLKXTHAW-NHCUHLMSSA-N (1r,2r)-2-[4-[4-[(6-chloro-1,3-benzoxazol-2-yl)amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC[C@H]1C(=O)C1=CC=C(C=2C=CC(NC=3OC4=CC(Cl)=CC=C4N=3)=CC=2)C=C1 HGLSWTPLKXTHAW-NHCUHLMSSA-N 0.000 claims 1
• KEHDTQPEHDUAIZ-FGZHOGPDSA-N (1r,2r)-2-[4-[4-[(6-methoxy-1h-benzimidazol-2-yl)amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound N=1C2=CC(OC)=CC=C2NC=1NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)[C@@H]1CCC[C@H]1C(O)=O KEHDTQPEHDUAIZ-FGZHOGPDSA-N 0.000 claims 1
• DATSYCBSXXSTCG-DHIUTWEWSA-N (1r,2r)-2-[4-[4-[(6-methyl-1,3-benzoxazol-2-yl)amino]phenyl]benzoyl]cyclohexane-1-carboxylic acid Chemical compound O1C2=CC(C)=CC=C2N=C1NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)[C@@H]1CCCC[C@H]1C(O)=O DATSYCBSXXSTCG-DHIUTWEWSA-N 0.000 claims 1
• BGLXNMBFRDEJQI-FGZHOGPDSA-N (1r,2r)-2-[4-[4-[(6-methyl-1,3-benzoxazol-2-yl)amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound O1C2=CC(C)=CC=C2N=C1NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)[C@@H]1CCC[C@H]1C(O)=O BGLXNMBFRDEJQI-FGZHOGPDSA-N 0.000 claims 1
• ZBULGTQMIIYDPZ-FGZHOGPDSA-N (1r,2r)-2-[4-[4-[(6-methylsulfonyl-1,3-benzothiazol-2-yl)amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound S1C2=CC(S(=O)(=O)C)=CC=C2N=C1NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)[C@@H]1CCC[C@H]1C(O)=O ZBULGTQMIIYDPZ-FGZHOGPDSA-N 0.000 claims 1
• PDMRVLAGTACACJ-NHCUHLMSSA-N (1r,2r)-2-[4-[4-[[6-(trifluoromethoxy)-1,3-benzothiazol-2-yl]amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC[C@H]1C(=O)C1=CC=C(C=2C=CC(NC=3SC4=CC(OC(F)(F)F)=CC=C4N=3)=CC=2)C=C1 PDMRVLAGTACACJ-NHCUHLMSSA-N 0.000 claims 1
• HLBVCUJLRDMIDC-NHCUHLMSSA-N (1r,2r)-2-[4-[4-[[6-(trifluoromethyl)-1,3-benzothiazol-2-yl]amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC[C@H]1C(=O)C1=CC=C(C=2C=CC(NC=3SC4=CC(=CC=C4N=3)C(F)(F)F)=CC=2)C=C1 HLBVCUJLRDMIDC-NHCUHLMSSA-N 0.000 claims 1
• ITUCWJIAHUMBNZ-NHCUHLMSSA-N (1r,2r)-2-[4-[4-[[6-(trifluoromethyl)-1h-benzimidazol-2-yl]amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC[C@H]1C(=O)C1=CC=C(C=2C=CC(NC=3NC4=CC=C(C=C4N=3)C(F)(F)F)=CC=2)C=C1 ITUCWJIAHUMBNZ-NHCUHLMSSA-N 0.000 claims 1
• FFPWIQJNMLVDBR-AHTUAUCYSA-N (1r,2r)-2-[[4-[3-fluoro-4-[(6-fluoro-1,3-benzothiazol-2-yl)amino]phenyl]phenyl]-hydroxymethyl]cyclopentane-1-carboxylic acid Chemical compound C=1C=C(C=2C=C(F)C(NC=3SC4=CC(F)=CC=C4N=3)=CC=2)C=CC=1C(O)[C@@H]1CCC[C@H]1C(O)=O FFPWIQJNMLVDBR-AHTUAUCYSA-N 0.000 claims 1
• HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 claims 1
• CABVTRNMFUVUDM-VRHQGPGLSA-N (3S)-3-hydroxy-3-methylglutaryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C[C@@](O)(CC(O)=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CABVTRNMFUVUDM-VRHQGPGLSA-N 0.000 claims 1
• 229940124681 11 beta HSD inhibitor Drugs 0.000 claims 1
• YBZYXVIFULNXRX-UHFFFAOYSA-N 2,2-dimethyl-4-[4-[4-[(5-methyl-1,3-benzoxazol-2-yl)amino]phenyl]phenyl]-4-oxobutanoic acid Chemical compound N=1C2=CC(C)=CC=C2OC=1NC(C=C1)=CC=C1C1=CC=C(C(=O)CC(C)(C)C(O)=O)C=C1 YBZYXVIFULNXRX-UHFFFAOYSA-N 0.000 claims 1
• NDZAGQKOVZOFJP-UHFFFAOYSA-N 2,2-dimethyl-4-oxo-4-[4-[4-(1,3-thiazol-2-ylamino)phenyl]phenyl]butanoic acid Chemical compound C1=CC(C(=O)CC(C)(C)C(O)=O)=CC=C1C(C=C1)=CC=C1NC1=NC=CS1 NDZAGQKOVZOFJP-UHFFFAOYSA-N 0.000 claims 1
• INIBSMAOXPURIL-UHFFFAOYSA-N 2,2-dimethyl-4-oxo-4-[4-[4-(5,6,7,8-tetrahydrobenzo[f][1,3]benzoxazol-2-ylamino)phenyl]phenyl]butanoic acid Chemical compound C1=CC(C(=O)CC(C)(C)C(O)=O)=CC=C1C(C=C1)=CC=C1NC(OC1=C2)=NC1=CC1=C2CCCC1 INIBSMAOXPURIL-UHFFFAOYSA-N 0.000 claims 1
• IOKNMADMEZDWAK-UHFFFAOYSA-N 2,2-dimethyl-4-oxo-4-[4-[4-[(5-propyl-1,3-benzoxazol-2-yl)amino]phenyl]phenyl]butanoic acid Chemical compound N=1C2=CC(CCC)=CC=C2OC=1NC(C=C1)=CC=C1C1=CC=C(C(=O)CC(C)(C)C(O)=O)C=C1 IOKNMADMEZDWAK-UHFFFAOYSA-N 0.000 claims 1
• RMFNPVMJUAXGIA-UHFFFAOYSA-N 2-[2-(dimethylamino)ethyl]-4-[4-[4-[(6-nitro-1,3-benzothiazol-2-yl)amino]phenyl]phenyl]-4-oxobutanoic acid Chemical compound C1=CC(C(=O)CC(CCN(C)C)C(O)=O)=CC=C1C(C=C1)=CC=C1NC1=NC2=CC=C([N+]([O-])=O)C=C2S1 RMFNPVMJUAXGIA-UHFFFAOYSA-N 0.000 claims 1
• JCXXFFTUDRICCJ-UHFFFAOYSA-N 2-[2-[4-[4-[(6-chloro-1,3-benzothiazol-2-yl)amino]phenyl]phenyl]-2-oxoethyl]pentanoic acid Chemical compound C1=CC(C(=O)CC(CCC)C(O)=O)=CC=C1C(C=C1)=CC=C1NC1=NC2=CC=C(Cl)C=C2S1 JCXXFFTUDRICCJ-UHFFFAOYSA-N 0.000 claims 1
• UMJOBTLRVPZBLC-UHFFFAOYSA-N 4-[4-[4-(1h-benzimidazol-2-ylamino)phenyl]phenyl]-2,2-dimethyl-4-oxobutanoic acid Chemical compound C1=CC(C(=O)CC(C)(C)C(O)=O)=CC=C1C(C=C1)=CC=C1NC1=NC2=CC=CC=C2N1 UMJOBTLRVPZBLC-UHFFFAOYSA-N 0.000 claims 1
• UPHKLTUEVXTBFJ-UHFFFAOYSA-N 4-[4-[4-[(5-methoxy-1,3-benzothiazol-2-yl)amino]phenyl]phenyl]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N=1C2=CC(OC)=CC=C2SC=1NC(C=C1)=CC=C1C1=CC=C(C(=O)CC(C)(C)C(O)=O)C=C1 UPHKLTUEVXTBFJ-UHFFFAOYSA-N 0.000 claims 1
• SVSZGEFXGDXMRA-UHFFFAOYSA-N 4-[4-[4-[(6-chloro-1,3-benzothiazol-2-yl)amino]-3-fluorophenyl]phenyl]-4-oxo-2-(2-phenylethyl)butanoic acid Chemical compound C=1C=C(C=2C=C(F)C(NC=3SC4=CC(Cl)=CC=C4N=3)=CC=2)C=CC=1C(=O)CC(C(=O)O)CCC1=CC=CC=C1 SVSZGEFXGDXMRA-UHFFFAOYSA-N 0.000 claims 1
• NDIPRIOGQSLBQK-UHFFFAOYSA-N 4-[4-[4-[(6-chloro-1,3-benzothiazol-2-yl)amino]phenyl]phenyl]-4-oxo-2-(2-phenylethyl)butanoic acid Chemical compound C=1C=C(C=2C=CC(NC=3SC4=CC(Cl)=CC=C4N=3)=CC=2)C=CC=1C(=O)CC(C(=O)O)CCC1=CC=CC=C1 NDIPRIOGQSLBQK-UHFFFAOYSA-N 0.000 claims 1
• VDTLFTSDFMXSTI-UHFFFAOYSA-N 4-[4-[4-[(6-chloro-1,3-benzoxazol-2-yl)amino]phenyl]phenyl]-2,2-dimethyl-4-oxobutanoic acid Chemical compound C1=CC(C(=O)CC(C)(C)C(O)=O)=CC=C1C(C=C1)=CC=C1NC1=NC2=CC=C(Cl)C=C2O1 VDTLFTSDFMXSTI-UHFFFAOYSA-N 0.000 claims 1
• APMHYWSOJGYZOC-UHFFFAOYSA-N 4-[4-[4-[(6-fluoro-1,3-benzothiazol-2-yl)amino]phenyl]phenyl]-2,2-dimethyl-4-oxobutanoic acid Chemical compound C1=CC(C(=O)CC(C)(C)C(O)=O)=CC=C1C(C=C1)=CC=C1NC1=NC2=CC=C(F)C=C2S1 APMHYWSOJGYZOC-UHFFFAOYSA-N 0.000 claims 1
• GPNFZYZYTPWBJZ-UHFFFAOYSA-N 4-[4-[4-[(6-methoxy-1,3-benzothiazol-2-yl)amino]phenyl]phenyl]-2,2-dimethyl-4-oxobutanoic acid Chemical compound S1C2=CC(OC)=CC=C2N=C1NC(C=C1)=CC=C1C1=CC=C(C(=O)CC(C)(C)C(O)=O)C=C1 GPNFZYZYTPWBJZ-UHFFFAOYSA-N 0.000 claims 1
• BFMGWIAJZCZUOF-UHFFFAOYSA-N 4-[4-[4-[(6-methoxy-1,3-benzothiazol-2-yl)amino]phenyl]phenyl]-2-(2-methoxyethyl)-4-oxobutanoic acid Chemical compound C1=CC(C(=O)CC(CCOC)C(O)=O)=CC=C1C(C=C1)=CC=C1NC1=NC2=CC=C(OC)C=C2S1 BFMGWIAJZCZUOF-UHFFFAOYSA-N 0.000 claims 1
• UWYNUZMGLLXFQH-UHFFFAOYSA-N 4-[4-[4-[(6-methoxy-1h-benzimidazol-2-yl)amino]phenyl]phenyl]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N=1C2=CC(OC)=CC=C2NC=1NC(C=C1)=CC=C1C1=CC=C(C(=O)CC(C)(C)C(O)=O)C=C1 UWYNUZMGLLXFQH-UHFFFAOYSA-N 0.000 claims 1
• XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 claims 1
• 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 claims 1
• 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 claims 1
• 239000003524 antilipemic agent Substances 0.000 claims 1
• 210000000941 bile Anatomy 0.000 claims 1
• TXWOGHSRPAYOML-UHFFFAOYSA-N cyclobutanecarboxylic acid Chemical compound OC(=O)C1CCC1 TXWOGHSRPAYOML-UHFFFAOYSA-N 0.000 claims 1
• 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
• 239000004026 insulin derivative Substances 0.000 claims 1
• 150000002823 nitrates Chemical class 0.000 claims 1
• 230000002265 prevention Effects 0.000 claims 1
• 239000003801 protein tyrosine phosphatase 1B inhibitor Substances 0.000 claims 1
• 239000004027 secretin derivative Substances 0.000 claims 1
• 150000003626 triacylglycerols Chemical class 0.000 abstract description 6
• 201000010099 disease Diseases 0.000 abstract description 5
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 403
• 239000000243 solution Substances 0.000 description 172
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 163
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 159
• 235000019439 ethyl acetate Nutrition 0.000 description 151
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 132
• 239000011541 reaction mixture Substances 0.000 description 119
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 101
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 98
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 90
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 87
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 84
• 239000007787 solid Substances 0.000 description 82
• 230000002829 reductive effect Effects 0.000 description 77
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 69
• XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 64
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 64
• 239000002904 solvent Substances 0.000 description 64
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 54
• 239000000543 intermediate Substances 0.000 description 52
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 46
• 239000010410 layer Substances 0.000 description 45
• 239000012044 organic layer Substances 0.000 description 44
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 43
• 238000003818 flash chromatography Methods 0.000 description 43
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 37
• LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 36
• 229920006395 saturated elastomer Polymers 0.000 description 35
• 239000000725 suspension Substances 0.000 description 35
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 32
• 229910052786 argon Inorganic materials 0.000 description 32
• 239000000047 product Substances 0.000 description 31
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 30
• 235000019441 ethanol Nutrition 0.000 description 30
• 230000014759 maintenance of location Effects 0.000 description 30
• 238000002390 rotary evaporation Methods 0.000 description 29
• 239000011734 sodium Substances 0.000 description 28
• 239000012267 brine Substances 0.000 description 27
• 238000001914 filtration Methods 0.000 description 27
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 27
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 26
• 239000003921 oil Substances 0.000 description 26
• 235000019198 oils Nutrition 0.000 description 26
• 239000012074 organic phase Substances 0.000 description 25
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 24
• 239000002244 precipitate Substances 0.000 description 23
• DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 23
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 21
• NXQGGXCHGDYOHB-UHFFFAOYSA-L [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium (II) Substances [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 21
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 21
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 20
• 239000000706 filtrate Substances 0.000 description 20
• 238000000746 purification Methods 0.000 description 20
• 238000010992 reflux Methods 0.000 description 20
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 19
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 19
• 239000000463 material Substances 0.000 description 18
• 238000003756 stirring Methods 0.000 description 18
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 17
• 239000003826 tablet Substances 0.000 description 17
• LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 16
• JBDSSBMEKXHSJF-UHFFFAOYSA-M cyclopentanecarboxylate Chemical compound [O-]C(=O)C1CCCC1 JBDSSBMEKXHSJF-UHFFFAOYSA-M 0.000 description 16
• 229910052757 nitrogen Inorganic materials 0.000 description 16
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
• 239000011780 sodium chloride Substances 0.000 description 15
• 229910052938 sodium sulfate Inorganic materials 0.000 description 15
• 235000011152 sodium sulphate Nutrition 0.000 description 15
• 238000006243 chemical reaction Methods 0.000 description 14
• 230000000694 effects Effects 0.000 description 14
• 238000004128 high performance liquid chromatography Methods 0.000 description 13
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
• QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 12
• 238000004007 reversed phase HPLC Methods 0.000 description 12
• SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 11
• 239000007858 starting material Substances 0.000 description 11
• 229940124597 therapeutic agent Drugs 0.000 description 11
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
• 241000699670 Mus sp. Species 0.000 description 10
• 238000005481 NMR spectroscopy Methods 0.000 description 10
• 239000012043 crude product Substances 0.000 description 10
• BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 10
• 239000004480 active ingredient Substances 0.000 description 9
• 210000004027 cell Anatomy 0.000 description 9
• 238000001816 cooling Methods 0.000 description 9
• 125000004433 nitrogen atom Chemical group N* 0.000 description 9
• QDZGJGWDGLHVNK-UHFFFAOYSA-N 2,6-dichloro-1,3-benzothiazole Chemical compound C1=C(Cl)C=C2SC(Cl)=NC2=C1 QDZGJGWDGLHVNK-UHFFFAOYSA-N 0.000 description 8
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
• 241001465754 Metazoa Species 0.000 description 8
• 230000037396 body weight Effects 0.000 description 8
• 230000005587 bubbling Effects 0.000 description 8
• 239000002775 capsule Substances 0.000 description 8
• 150000007942 carboxylates Chemical class 0.000 description 8
• 235000011187 glycerol Nutrition 0.000 description 8
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 8
• 229910052742 iron Inorganic materials 0.000 description 8
• 239000000741 silica gel Substances 0.000 description 8
• 229910002027 silica gel Inorganic materials 0.000 description 8
• 229960001866 silicon dioxide Drugs 0.000 description 8
• 229910000029 sodium carbonate Inorganic materials 0.000 description 8
• SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 7
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 7
• HEWZVZIVELJPQZ-UHFFFAOYSA-N 2,2-dimethoxypropane Chemical compound COC(C)(C)OC HEWZVZIVELJPQZ-UHFFFAOYSA-N 0.000 description 7
• 125000002672 4-bromobenzoyl group Chemical group BrC1=CC=C(C(=O)*)C=C1 0.000 description 7
• 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 7
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
• 125000000217 alkyl group Chemical group 0.000 description 7
• 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 7
• 238000004296 chiral HPLC Methods 0.000 description 7
• 239000003086 colorant Substances 0.000 description 7
• ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 7
• 235000005911 diet Nutrition 0.000 description 7
• 125000005843 halogen group Chemical group 0.000 description 7
• 239000005457 ice water Substances 0.000 description 7
• QQIBWNNOJLMPER-UHFFFAOYSA-N methyl 4-[4-(4-aminophenyl)phenyl]-2,2-dimethyl-4-oxobutanoate Chemical compound C1=CC(C(=O)CC(C)(C)C(=O)OC)=CC=C1C1=CC=C(N)C=C1 QQIBWNNOJLMPER-UHFFFAOYSA-N 0.000 description 7
• 229920000609 methyl cellulose Polymers 0.000 description 7
• 235000010981 methylcellulose Nutrition 0.000 description 7
• 239000001923 methylcellulose Substances 0.000 description 7
• 229960002900 methylcellulose Drugs 0.000 description 7
• 239000002480 mineral oil Substances 0.000 description 7
• 239000003755 preservative agent Substances 0.000 description 7
• 239000000377 silicon dioxide Substances 0.000 description 7
• 238000001228 spectrum Methods 0.000 description 7
• 208000024891 symptom Diseases 0.000 description 7
• 238000004809 thin layer chromatography Methods 0.000 description 7
• WIKBZUXHNPONPP-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoro-2-iodo-2-(trifluoromethyl)propane Chemical compound FC(F)(F)C(I)(C(F)(F)F)C(F)(F)F WIKBZUXHNPONPP-UHFFFAOYSA-N 0.000 description 6
• BSQLQMLFTHJVKS-UHFFFAOYSA-N 2-chloro-1,3-benzothiazole Chemical compound C1=CC=C2SC(Cl)=NC2=C1 BSQLQMLFTHJVKS-UHFFFAOYSA-N 0.000 description 6
• MSDJYMDOERLSEH-UHFFFAOYSA-N 2-chloro-5,7-difluoro-1,3-benzothiazole Chemical compound FC1=CC(F)=C2SC(Cl)=NC2=C1 MSDJYMDOERLSEH-UHFFFAOYSA-N 0.000 description 6
• FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 6
• AIBQGOMAISTKSR-UHFFFAOYSA-N 6-chloro-1,3-benzothiazole Chemical compound ClC1=CC=C2N=CSC2=C1 AIBQGOMAISTKSR-UHFFFAOYSA-N 0.000 description 6
• WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 6
• 229930006000 Sucrose Natural products 0.000 description 6
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
• 150000001412 amines Chemical class 0.000 description 6
• 239000003599 detergent Substances 0.000 description 6
• 230000037213 diet Effects 0.000 description 6
• 239000003085 diluting agent Substances 0.000 description 6
• 239000000796 flavoring agent Substances 0.000 description 6
• 239000007788 liquid Substances 0.000 description 6
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
• 235000010446 mineral oil Nutrition 0.000 description 6
• LGEPQFZGDQOFFH-UHFFFAOYSA-N n-(2-fluoro-4-iodophenyl)formamide Chemical compound FC1=CC(I)=CC=C1NC=O LGEPQFZGDQOFFH-UHFFFAOYSA-N 0.000 description 6
• NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 6
• 229920001223 polyethylene glycol Polymers 0.000 description 6
• 239000000843 powder Substances 0.000 description 6
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
• 235000017557 sodium bicarbonate Nutrition 0.000 description 6
• 239000012312 sodium hydride Substances 0.000 description 6
• 229910000104 sodium hydride Inorganic materials 0.000 description 6
• 239000005720 sucrose Substances 0.000 description 6
• 239000000375 suspending agent Substances 0.000 description 6
• 235000020357 syrup Nutrition 0.000 description 6
• 239000006188 syrup Substances 0.000 description 6
• BVTWSRUFFHBCHO-GHMZBOCLSA-N (1r,2r)-2-(4-bromobenzoyl)cyclopentane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC[C@H]1C(=O)C1=CC=C(Br)C=C1 BVTWSRUFFHBCHO-GHMZBOCLSA-N 0.000 description 5
• LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 5
• KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 5
• ZSKXYSCQDWAUCM-UHFFFAOYSA-N 1-(chloromethyl)-2-dodecylbenzene Chemical compound CCCCCCCCCCCCC1=CC=CC=C1CCl ZSKXYSCQDWAUCM-UHFFFAOYSA-N 0.000 description 5
• LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 5
• VDBCLRHHWCDXKG-UHFFFAOYSA-N 6-methyl-2-methylsulfonyl-1,3-benzoxazole Chemical compound CC1=CC=C2N=C(S(C)(=O)=O)OC2=C1 VDBCLRHHWCDXKG-UHFFFAOYSA-N 0.000 description 5
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 5
• 229920002261 Corn starch Polymers 0.000 description 5
• IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 5
• 229960000583 acetic acid Drugs 0.000 description 5
• 150000001298 alcohols Chemical class 0.000 description 5
• 235000010443 alginic acid Nutrition 0.000 description 5
• 229920000615 alginic acid Polymers 0.000 description 5
• 238000003556 assay Methods 0.000 description 5
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
• IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 5
• 239000007859 condensation product Substances 0.000 description 5
• 239000008120 corn starch Substances 0.000 description 5
• WAGKABSLTMJJOA-UHFFFAOYSA-N ethyl 4-[4-(4-aminophenyl)phenyl]-2-(2-methoxyethyl)-4-oxobutanoate Chemical compound C1=CC(C(=O)CC(CCOC)C(=O)OCC)=CC=C1C1=CC=C(N)C=C1 WAGKABSLTMJJOA-UHFFFAOYSA-N 0.000 description 5
• 235000003599 food sweetener Nutrition 0.000 description 5
• 238000010438 heat treatment Methods 0.000 description 5
• 238000002347 injection Methods 0.000 description 5
• 239000007924 injection Substances 0.000 description 5
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 5
• XKJACWYQAFNKQK-VXGBXAGGSA-N methyl (1r,2r)-2-(4-bromobenzoyl)cyclopentane-1-carboxylate Chemical compound COC(=O)[C@@H]1CCC[C@H]1C(=O)C1=CC=C(Br)C=C1 XKJACWYQAFNKQK-VXGBXAGGSA-N 0.000 description 5
• APNJFPTUUUQXLI-NXEZZACHSA-N methyl (1r,2r)-2-(4-bromobenzoyl)cyclopropane-1-carboxylate Chemical compound COC(=O)[C@@H]1C[C@H]1C(=O)C1=CC=C(Br)C=C1 APNJFPTUUUQXLI-NXEZZACHSA-N 0.000 description 5
• UXILPKFDYIXPOS-IAGOWNOFSA-N methyl (1r,2r)-2-[4-(4-aminophenyl)benzoyl]cyclobutane-1-carboxylate Chemical compound COC(=O)[C@@H]1CC[C@H]1C(=O)C1=CC=C(C=2C=CC(N)=CC=2)C=C1 UXILPKFDYIXPOS-IAGOWNOFSA-N 0.000 description 5
• DPUUNEZEFLAPQM-UHFFFAOYSA-N methyl 4-(4-bromophenyl)-2,2-dimethyl-4-oxobutanoate Chemical compound COC(=O)C(C)(C)CC(=O)C1=CC=C(Br)C=C1 DPUUNEZEFLAPQM-UHFFFAOYSA-N 0.000 description 5
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 5
• YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 5
• 235000011056 potassium acetate Nutrition 0.000 description 5
• 229940002612 prodrug Drugs 0.000 description 5
• 239000000651 prodrug Substances 0.000 description 5
• 235000013772 propylene glycol Nutrition 0.000 description 5
• 108090000623 proteins and genes Proteins 0.000 description 5
• 239000000126 substance Substances 0.000 description 5
• 239000004094 surface-active agent Substances 0.000 description 5
• 239000003765 sweetening agent Substances 0.000 description 5
• 239000000080 wetting agent Substances 0.000 description 5
• HDQWFHUGMKRYIN-UHFFFAOYSA-N (3,5-difluorophenyl)thiourea Chemical compound NC(=S)NC1=CC(F)=CC(F)=C1 HDQWFHUGMKRYIN-UHFFFAOYSA-N 0.000 description 4
• XQACWEBGSZBLRG-UHFFFAOYSA-N 1-bromo-4-isothiocyanatobenzene Chemical compound BrC1=CC=C(N=C=S)C=C1 XQACWEBGSZBLRG-UHFFFAOYSA-N 0.000 description 4
• VFELEJMYVUPGEO-UHFFFAOYSA-N 2-chloro-5,6-difluoro-1h-benzimidazole Chemical compound C1=C(F)C(F)=CC2=C1NC(Cl)=N2 VFELEJMYVUPGEO-UHFFFAOYSA-N 0.000 description 4
• VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
• PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
• 108010001348 Diacylglycerol O-acyltransferase Proteins 0.000 description 4
• 102000002148 Diacylglycerol O-acyltransferase Human genes 0.000 description 4
• XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
• 102000004190 Enzymes Human genes 0.000 description 4
• 108090000790 Enzymes Proteins 0.000 description 4
• 108010010803 Gelatin Proteins 0.000 description 4
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 4
• 240000007472 Leucaena leucocephala Species 0.000 description 4
• 241000124008 Mammalia Species 0.000 description 4
• HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 4
• 235000019502 Orange oil Nutrition 0.000 description 4
• 101150003085 Pdcl gene Proteins 0.000 description 4
• 235000019483 Peanut oil Nutrition 0.000 description 4
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
• YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 4
• 235000021355 Stearic acid Nutrition 0.000 description 4
• 229920001615 Tragacanth Polymers 0.000 description 4
• HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 4
• 210000000593 adipose tissue white Anatomy 0.000 description 4
• 239000000783 alginic acid Substances 0.000 description 4
• 229960001126 alginic acid Drugs 0.000 description 4
• 150000004781 alginic acids Chemical class 0.000 description 4
• VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
• 235000011114 ammonium hydroxide Nutrition 0.000 description 4
• 239000007864 aqueous solution Substances 0.000 description 4
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
• IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 4
• 230000015572 biosynthetic process Effects 0.000 description 4
• 239000000872 buffer Substances 0.000 description 4
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
• FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 4
• 229910000024 caesium carbonate Inorganic materials 0.000 description 4
• 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
• 229960000541 cetyl alcohol Drugs 0.000 description 4
• NZNMSOFKMUBTKW-UHFFFAOYSA-M cyclohexanecarboxylate Chemical compound [O-]C(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-M 0.000 description 4
• 238000007872 degassing Methods 0.000 description 4
• ZDXVIAQODWQTEN-UHFFFAOYSA-N diethyl 2-[2-(4-bromophenyl)-2-oxoethyl]-2-(2-phenylethyl)propanedioate Chemical compound C=1C=C(Br)C=CC=1C(=O)CC(C(=O)OCC)(C(=O)OCC)CCC1=CC=CC=C1 ZDXVIAQODWQTEN-UHFFFAOYSA-N 0.000 description 4
• 239000002270 dispersing agent Substances 0.000 description 4
• 238000001035 drying Methods 0.000 description 4
• 239000003995 emulsifying agent Substances 0.000 description 4
• 239000000284 extract Substances 0.000 description 4
• 235000013355 food flavoring agent Nutrition 0.000 description 4
• 239000008273 gelatin Substances 0.000 description 4
• 229920000159 gelatin Polymers 0.000 description 4
• 235000019322 gelatine Nutrition 0.000 description 4
• 235000011852 gelatine desserts Nutrition 0.000 description 4
• 150000002430 hydrocarbons Chemical group 0.000 description 4
• 238000006460 hydrolysis reaction Methods 0.000 description 4
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 4
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 4
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 4
• OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 description 4
• 235000010445 lecithin Nutrition 0.000 description 4
• 239000000787 lecithin Substances 0.000 description 4
• 229940067606 lecithin Drugs 0.000 description 4
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
• 235000019341 magnesium sulphate Nutrition 0.000 description 4
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
• LGQJVLXDNCWQDQ-UHFFFAOYSA-N methyl 3-[4-(4-aminophenyl)benzoyl]cyclohexane-1-carboxylate Chemical compound C1C(C(=O)OC)CCCC1C(=O)C1=CC=C(C=2C=CC(N)=CC=2)C=C1 LGQJVLXDNCWQDQ-UHFFFAOYSA-N 0.000 description 4
• GFIWNYBWTGTHKV-UHFFFAOYSA-N methyl 4-[2-(4-bromophenyl)-2-oxoethyl]oxane-4-carboxylate Chemical compound C=1C=C(Br)C=CC=1C(=O)CC1(C(=O)OC)CCOCC1 GFIWNYBWTGTHKV-UHFFFAOYSA-N 0.000 description 4
• GMODUIWPJWRFCZ-UHFFFAOYSA-N methyl 4-[4-(4-amino-3-fluorophenyl)phenyl]-2,2-dimethyl-4-oxobutanoate Chemical compound C1=CC(C(=O)CC(C)(C)C(=O)OC)=CC=C1C1=CC=C(N)C(F)=C1 GMODUIWPJWRFCZ-UHFFFAOYSA-N 0.000 description 4
• QWHJLCYQHQLERS-UHFFFAOYSA-N n-(4-bromo-2-fluorophenyl)-4-methyl-1,3-benzothiazol-2-amine Chemical compound N=1C=2C(C)=CC=CC=2SC=1NC1=CC=C(Br)C=C1F QWHJLCYQHQLERS-UHFFFAOYSA-N 0.000 description 4
• 231100000252 nontoxic Toxicity 0.000 description 4
• 230000003000 nontoxic effect Effects 0.000 description 4
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
• 239000002674 ointment Substances 0.000 description 4
• 239000010502 orange oil Substances 0.000 description 4
• 230000036961 partial effect Effects 0.000 description 4
• 239000000312 peanut oil Substances 0.000 description 4
• 239000012071 phase Substances 0.000 description 4
• HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 description 4
• QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
• 125000006239 protecting group Chemical group 0.000 description 4
• 239000000523 sample Substances 0.000 description 4
• 239000008159 sesame oil Substances 0.000 description 4
• 235000011803 sesame oil Nutrition 0.000 description 4
• 239000000600 sorbitol Substances 0.000 description 4
• 235000010356 sorbitol Nutrition 0.000 description 4
• 239000008117 stearic acid Substances 0.000 description 4
• YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 4
• NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 4
• 235000015112 vegetable and seed oil Nutrition 0.000 description 4
• 239000008158 vegetable oil Substances 0.000 description 4
• YKLCGTKYEXHOQG-NXEZZACHSA-N (1r,2r)-2-(4-bromobenzoyl)cyclobutane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CC[C@H]1C(=O)C1=CC=C(Br)C=C1 YKLCGTKYEXHOQG-NXEZZACHSA-N 0.000 description 3
• FFFCOGICKMRJSG-RKDXNWHRSA-N (1r,2r)-2-(4-bromobenzoyl)cyclopropane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1C[C@H]1C(=O)C1=CC=C(Br)C=C1 FFFCOGICKMRJSG-RKDXNWHRSA-N 0.000 description 3
• MUWRTYJKLDGPJT-UHFFFAOYSA-N (4-acetyl-3-methylphenyl) trifluoromethanesulfonate Chemical compound CC(=O)C1=CC=C(OS(=O)(=O)C(F)(F)F)C=C1C MUWRTYJKLDGPJT-UHFFFAOYSA-N 0.000 description 3
• WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
• 0 *C(PC(N)=O)=O Chemical compound *C(PC(N)=O)=O 0.000 description 3
• ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 3
• QSNZNVNQLNRJFE-UHFFFAOYSA-N 1-(4-iodophenyl)-3-(4-methylphenyl)thiourea Chemical compound C1=CC(C)=CC=C1NC(=S)NC1=CC=C(I)C=C1 QSNZNVNQLNRJFE-UHFFFAOYSA-N 0.000 description 3
• AUQPWLICEFPGRR-UHFFFAOYSA-N 1-[2-methyl-4-(4-nitrophenyl)phenyl]ethanone Chemical compound C1=C(C)C(C(=O)C)=CC=C1C1=CC=C([N+]([O-])=O)C=C1 AUQPWLICEFPGRR-UHFFFAOYSA-N 0.000 description 3
• IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 3
• UCHQXJWIIPEFFX-UHFFFAOYSA-N 2-(4-methoxycarbonyloxan-4-yl)acetic acid Chemical compound COC(=O)C1(CC(O)=O)CCOCC1 UCHQXJWIIPEFFX-UHFFFAOYSA-N 0.000 description 3
• BHTKIYIEMXRHGL-UHFFFAOYSA-N 2-amino-4-(trifluoromethyl)phenol Chemical compound NC1=CC(C(F)(F)F)=CC=C1O BHTKIYIEMXRHGL-UHFFFAOYSA-N 0.000 description 3
• RXNZFHIEDZEUQM-UHFFFAOYSA-N 2-bromo-1,3-thiazole Chemical class BrC1=NC=CS1 RXNZFHIEDZEUQM-UHFFFAOYSA-N 0.000 description 3
• XYDOQYMDGXHRLU-UHFFFAOYSA-N 2-bromo-1-[2-methyl-4-(4-nitrophenyl)phenyl]ethanone Chemical compound C1=C(C(=O)CBr)C(C)=CC(C=2C=CC(=CC=2)[N+]([O-])=O)=C1 XYDOQYMDGXHRLU-UHFFFAOYSA-N 0.000 description 3
• AYPSHJCKSDNETA-UHFFFAOYSA-N 2-chloro-1h-benzimidazole Chemical class C1=CC=C2NC(Cl)=NC2=C1 AYPSHJCKSDNETA-UHFFFAOYSA-N 0.000 description 3
• LZXONCQHRWRSKB-UHFFFAOYSA-N 2-chloro-4,6-difluoro-1,3-benzothiazole Chemical compound FC1=CC(F)=C2N=C(Cl)SC2=C1 LZXONCQHRWRSKB-UHFFFAOYSA-N 0.000 description 3
• NYNLRPVNVRAELQ-UHFFFAOYSA-N 2-chloro-4-methyl-1,3-benzothiazole Chemical compound CC1=CC=CC2=C1N=C(Cl)S2 NYNLRPVNVRAELQ-UHFFFAOYSA-N 0.000 description 3
• YIRRVMGAKFESLR-UHFFFAOYSA-N 2-chloro-6-(trifluoromethyl)-1,3-benzothiazole Chemical compound FC(F)(F)C1=CC=C2N=C(Cl)SC2=C1 YIRRVMGAKFESLR-UHFFFAOYSA-N 0.000 description 3
• 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 3
• ZIYQPNXDQOUTAT-IAGOWNOFSA-N 2-trimethylsilylethyl (1r,2r)-2-(4-bromobenzoyl)cyclohexane-1-carboxylate Chemical compound C[Si](C)(C)CCOC(=O)[C@@H]1CCCC[C@H]1C(=O)C1=CC=C(Br)C=C1 ZIYQPNXDQOUTAT-IAGOWNOFSA-N 0.000 description 3
• LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
• ULZYBRSOSIIFAE-UHFFFAOYSA-N 4,6-difluoro-1,3-benzothiazole Chemical compound FC1=CC(F)=C2N=CSC2=C1 ULZYBRSOSIIFAE-UHFFFAOYSA-N 0.000 description 3
• KRHOXMGEWXKCIB-UHFFFAOYSA-N 4-(4-bromophenyl)-2,2-dimethyl-4-oxobutanoic acid Chemical compound OC(=O)C(C)(C)CC(=O)C1=CC=C(Br)C=C1 KRHOXMGEWXKCIB-UHFFFAOYSA-N 0.000 description 3
• ARMZWEKTPLCJKD-UHFFFAOYSA-N 5,6-difluoro-1h-benzimidazol-2-amine Chemical compound FC1=C(F)C=C2NC(N)=NC2=C1 ARMZWEKTPLCJKD-UHFFFAOYSA-N 0.000 description 3
• OEEBJKDZPLDBQI-UHFFFAOYSA-N 5,7-difluoro-1,3-benzothiazol-2-amine Chemical compound FC1=CC(F)=C2SC(N)=NC2=C1 OEEBJKDZPLDBQI-UHFFFAOYSA-N 0.000 description 3
• DJRUWESABPZMRB-UHFFFAOYSA-N 5-(trifluoromethyl)-3h-1,3-benzothiazole-2-thione Chemical compound FC(F)(F)C1=CC=C2SC(=S)NC2=C1 DJRUWESABPZMRB-UHFFFAOYSA-N 0.000 description 3
• JFEUORRSQKXCBD-UHFFFAOYSA-N 6-methyl-2-methylsulfanyl-1,3-benzoxazole Chemical compound C1=C(C)C=C2OC(SC)=NC2=C1 JFEUORRSQKXCBD-UHFFFAOYSA-N 0.000 description 3
• QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
• WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
• QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 3
• 102100036869 Diacylglycerol O-acyltransferase 1 Human genes 0.000 description 3
• 108050004099 Diacylglycerol O-acyltransferase 1 Proteins 0.000 description 3
• QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 3
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 3
• 241000282412 Homo Species 0.000 description 3
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
• 239000005642 Oleic acid Substances 0.000 description 3
• ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
• 239000004264 Petrolatum Substances 0.000 description 3
• 239000004698 Polyethylene Substances 0.000 description 3
• 101710182846 Polyhedrin Proteins 0.000 description 3
• KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
• 229920002125 Sokalan® Polymers 0.000 description 3
• GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
• WERKSKAQRVDLDW-ANOHMWSOSA-N [(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO WERKSKAQRVDLDW-ANOHMWSOSA-N 0.000 description 3
• 238000010521 absorption reaction Methods 0.000 description 3
• 125000003277 amino group Chemical group 0.000 description 3
• 239000000908 ammonium hydroxide Substances 0.000 description 3
• 238000004458 analytical method Methods 0.000 description 3
• 239000005557 antagonist Substances 0.000 description 3
• 235000010323 ascorbic acid Nutrition 0.000 description 3
• 239000000440 bentonite Substances 0.000 description 3
• 229940092782 bentonite Drugs 0.000 description 3
• 229910000278 bentonite Inorganic materials 0.000 description 3
• SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 3
• 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 3
• 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 235000005687 corn oil Nutrition 0.000 description 3
• 239000002285 corn oil Substances 0.000 description 3
• GCUVBACNBHGZRS-UHFFFAOYSA-N cyclopenta-1,3-diene cyclopenta-2,4-dien-1-yl(diphenyl)phosphane iron(2+) Chemical compound [Fe++].c1cc[cH-]c1.c1cc[c-](c1)P(c1ccccc1)c1ccccc1 GCUVBACNBHGZRS-UHFFFAOYSA-N 0.000 description 3
• 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
• 230000018044 dehydration Effects 0.000 description 3
• 238000006297 dehydration reaction Methods 0.000 description 3
• 239000008121 dextrose Substances 0.000 description 3
• ODUCYGOHJXLCSO-UHFFFAOYSA-N diethyl 2-[2-[2-methyl-4-(4-nitrophenyl)phenyl]-2-oxoethyl]-2-(2-phenylethyl)propanedioate Chemical compound C=1C=C(C=2C=CC(=CC=2)[N+]([O-])=O)C=C(C)C=1C(=O)CC(C(=O)OCC)(C(=O)OCC)CCC1=CC=CC=C1 ODUCYGOHJXLCSO-UHFFFAOYSA-N 0.000 description 3
• 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
• UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
• 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
• 239000002552 dosage form Substances 0.000 description 3
• 239000000839 emulsion Substances 0.000 description 3
• 150000002170 ethers Chemical class 0.000 description 3
• MTNHWJLBQCDXKE-UHFFFAOYSA-N ethyl 4-(4-bromophenyl)-4-oxo-2-(2-phenylethyl)butanoate Chemical compound C=1C=C(Br)C=CC=1C(=O)CC(C(=O)OCC)CCC1=CC=CC=C1 MTNHWJLBQCDXKE-UHFFFAOYSA-N 0.000 description 3
• LHARMCKIKFVYBY-UHFFFAOYSA-N ethyl 4-[2-methyl-4-(4-nitrophenyl)phenyl]-4-oxo-2-(2-phenylethyl)butanoate Chemical compound C=1C=C(C=2C=CC(=CC=2)[N+]([O-])=O)C=C(C)C=1C(=O)CC(C(=O)OCC)CCC1=CC=CC=C1 LHARMCKIKFVYBY-UHFFFAOYSA-N 0.000 description 3
• DOUGTDRMIBYZBO-UHFFFAOYSA-N ethyl 4-[4-(4-aminophenyl)phenyl]-4-oxo-2-(2-phenylethyl)butanoate Chemical compound C=1C=C(C=2C=CC(N)=CC=2)C=CC=1C(=O)CC(C(=O)OCC)CCC1=CC=CC=C1 DOUGTDRMIBYZBO-UHFFFAOYSA-N 0.000 description 3
• 239000012065 filter cake Substances 0.000 description 3
• 235000013305 food Nutrition 0.000 description 3
• FATAVLOOLIRUNA-UHFFFAOYSA-N formylmethyl Chemical group [CH2]C=O FATAVLOOLIRUNA-UHFFFAOYSA-N 0.000 description 3
• 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 3
• 230000007062 hydrolysis Effects 0.000 description 3
• 230000005764 inhibitory process Effects 0.000 description 3
• 150000002500 ions Chemical class 0.000 description 3
• QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
• 239000008101 lactose Substances 0.000 description 3
• 239000000314 lubricant Substances 0.000 description 3
• 235000019359 magnesium stearate Nutrition 0.000 description 3
• 238000004949 mass spectrometry Methods 0.000 description 3
• 239000012528 membrane Substances 0.000 description 3
• XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 3
• BBXUKSLWCNJNIZ-UHFFFAOYSA-N methyl 1-[2-(4-bromophenyl)-2-oxoethyl]cyclopentane-1-carboxylate Chemical compound C=1C=C(Br)C=CC=1C(=O)CC1(C(=O)OC)CCCC1 BBXUKSLWCNJNIZ-UHFFFAOYSA-N 0.000 description 3
• SYTYBXDUZDVVQC-UHFFFAOYSA-N methyl 1-[2-[4-(4-aminophenyl)phenyl]-2-oxoethyl]cyclopentane-1-carboxylate Chemical compound C=1C=C(C=2C=CC(N)=CC=2)C=CC=1C(=O)CC1(C(=O)OC)CCCC1 SYTYBXDUZDVVQC-UHFFFAOYSA-N 0.000 description 3
• QRLBPMZCKFLVSQ-UHFFFAOYSA-N methyl 3-(4-bromobenzoyl)cyclohexane-1-carboxylate Chemical compound C1C(C(=O)OC)CCCC1C(=O)C1=CC=C(Br)C=C1 QRLBPMZCKFLVSQ-UHFFFAOYSA-N 0.000 description 3
• UNBHFTHUGGFEEF-UHFFFAOYSA-N methyl 4-(2-chloro-2-oxoethyl)oxane-4-carboxylate Chemical compound COC(=O)C1(CC(Cl)=O)CCOCC1 UNBHFTHUGGFEEF-UHFFFAOYSA-N 0.000 description 3
• RPBNTVSYXGORMY-UHFFFAOYSA-N methyl 4-[2-[4-(4-aminophenyl)phenyl]-2-oxoethyl]oxane-4-carboxylate Chemical compound C=1C=C(C=2C=CC(N)=CC=2)C=CC=1C(=O)CC1(C(=O)OC)CCOCC1 RPBNTVSYXGORMY-UHFFFAOYSA-N 0.000 description 3
• SVDFLEHZPDWABL-UHFFFAOYSA-N methyl 4-[4-(4-amino-3-methoxyphenyl)phenyl]-2,2-dimethyl-4-oxobutanoate Chemical compound C1=CC(C(=O)CC(C)(C)C(=O)OC)=CC=C1C1=CC=C(N)C(OC)=C1 SVDFLEHZPDWABL-UHFFFAOYSA-N 0.000 description 3
• CAKQINBQFMSFNB-UHFFFAOYSA-N methyl 4-[4-(4-formamidophenyl)phenyl]-2,2-dimethyl-4-oxobutanoate Chemical compound C1=CC(C(=O)CC(C)(C)C(=O)OC)=CC=C1C1=CC=C(NC=O)C=C1 CAKQINBQFMSFNB-UHFFFAOYSA-N 0.000 description 3
• CNCMVGXVKBJYNU-UHFFFAOYSA-N methyl oxane-4-carboxylate Chemical compound COC(=O)C1CCOCC1 CNCMVGXVKBJYNU-UHFFFAOYSA-N 0.000 description 3
• 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
• UIRBZPCHDIBABB-UHFFFAOYSA-N n-(4-bromophenyl)-5-(trifluoromethyl)-1,3-benzoxazol-2-amine Chemical compound N=1C2=CC(C(F)(F)F)=CC=C2OC=1NC1=CC=C(Br)C=C1 UIRBZPCHDIBABB-UHFFFAOYSA-N 0.000 description 3
• ULQHAHDNKMTMBV-UHFFFAOYSA-N n-(4-bromophenyl)-5-methyl-1,3-benzoxazol-2-amine Chemical compound N=1C2=CC(C)=CC=C2OC=1NC1=CC=C(Br)C=C1 ULQHAHDNKMTMBV-UHFFFAOYSA-N 0.000 description 3
• YVMPHQNOYFUDNO-UHFFFAOYSA-N n-(4-iodophenyl)formamide Chemical compound IC1=CC=C(NC=O)C=C1 YVMPHQNOYFUDNO-UHFFFAOYSA-N 0.000 description 3
• 239000012299 nitrogen atmosphere Substances 0.000 description 3
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
• 239000004006 olive oil Substances 0.000 description 3
• 235000008390 olive oil Nutrition 0.000 description 3
• PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 3
• 239000012188 paraffin wax Substances 0.000 description 3
• 239000008188 pellet Substances 0.000 description 3
• 235000019271 petrolatum Nutrition 0.000 description 3
• 229940066842 petrolatum Drugs 0.000 description 3
• 229920000573 polyethylene Polymers 0.000 description 3
• 229920000642 polymer Polymers 0.000 description 3
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
• 230000008569 process Effects 0.000 description 3
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
• 238000000926 separation method Methods 0.000 description 3
• 235000010413 sodium alginate Nutrition 0.000 description 3
• 239000000661 sodium alginate Substances 0.000 description 3
• 229940005550 sodium alginate Drugs 0.000 description 3
• 235000011069 sorbitan monooleate Nutrition 0.000 description 3
• 239000001593 sorbitan monooleate Substances 0.000 description 3
• 229940035049 sorbitan monooleate Drugs 0.000 description 3
• 235000000346 sugar Nutrition 0.000 description 3
• 239000000454 talc Substances 0.000 description 3
• 229910052623 talc Inorganic materials 0.000 description 3
• 235000012222 talc Nutrition 0.000 description 3
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
• IOGXOCVLYRDXLW-UHFFFAOYSA-N tert-butyl nitrite Chemical compound CC(C)(C)ON=O IOGXOCVLYRDXLW-UHFFFAOYSA-N 0.000 description 3
• 239000012414 tert-butyl nitrite Substances 0.000 description 3
• 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
• 239000003981 vehicle Substances 0.000 description 3
• 239000001993 wax Substances 0.000 description 3
• DMHXIMFDDZPBRN-FGZHOGPDSA-N (1r,2r)-2-[4-[4-[(6-chloro-1,3-benzothiazol-2-yl)amino]phenyl]benzoyl]cyclohexane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCC[C@H]1C(=O)C1=CC=C(C=2C=CC(NC=3SC4=CC(Cl)=CC=C4N=3)=CC=2)C=C1 DMHXIMFDDZPBRN-FGZHOGPDSA-N 0.000 description 2
• 125000006528 (C2-C6) alkyl group Chemical group 0.000 description 2
• WYECURVXVYPVAT-UHFFFAOYSA-N 1-(4-bromophenyl)ethanone Chemical compound CC(=O)C1=CC=C(Br)C=C1 WYECURVXVYPVAT-UHFFFAOYSA-N 0.000 description 2
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
• XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
• UHGULLIUJBCTEF-UHFFFAOYSA-N 2-aminobenzothiazole Chemical class C1=CC=C2SC(N)=NC2=C1 UHGULLIUJBCTEF-UHFFFAOYSA-N 0.000 description 2
• CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 2
• ANIJFZVZXZQFDH-UHFFFAOYSA-N 2-bromo-5-nitro-1,3-thiazole Chemical compound [O-][N+](=O)C1=CN=C(Br)S1 ANIJFZVZXZQFDH-UHFFFAOYSA-N 0.000 description 2
• YXXCZHJSELQADZ-UHFFFAOYSA-N 2-chloro-1,3-benzoxazole-5-carbonitrile Chemical compound N#CC1=CC=C2OC(Cl)=NC2=C1 YXXCZHJSELQADZ-UHFFFAOYSA-N 0.000 description 2
• UXZYKSFMGDWHGJ-UHFFFAOYSA-N 2-chloro-1-methylbenzimidazole Chemical compound C1=CC=C2N(C)C(Cl)=NC2=C1 UXZYKSFMGDWHGJ-UHFFFAOYSA-N 0.000 description 2
• KMHYDRGLBQZDAE-UHFFFAOYSA-N 2-chloro-5-(trifluoromethyl)-1,3-benzothiazole Chemical compound FC(F)(F)C1=CC=C2SC(Cl)=NC2=C1 KMHYDRGLBQZDAE-UHFFFAOYSA-N 0.000 description 2
• IHMBREJYLPBYSM-UHFFFAOYSA-N 2-chloro-5-fluoro-1,3-benzothiazole Chemical compound FC1=CC=C2SC(Cl)=NC2=C1 IHMBREJYLPBYSM-UHFFFAOYSA-N 0.000 description 2
• PPGSYGPSOLZOOU-UHFFFAOYSA-N 2-chloro-6-(trifluoromethoxy)-1,3-benzothiazole Chemical compound FC(F)(F)OC1=CC=C2N=C(Cl)SC2=C1 PPGSYGPSOLZOOU-UHFFFAOYSA-N 0.000 description 2
• ISIIQFDYFMPPOA-UHFFFAOYSA-N 2-chloro-6-fluoro-1,3-benzothiazole Chemical compound FC1=CC=C2N=C(Cl)SC2=C1 ISIIQFDYFMPPOA-UHFFFAOYSA-N 0.000 description 2
• CUMTUBVTKOYYOU-UHFFFAOYSA-N 2-fluoro-4-iodoaniline Chemical compound NC1=CC=C(I)C=C1F CUMTUBVTKOYYOU-UHFFFAOYSA-N 0.000 description 2
• 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 2
• WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
• NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
• RQWJHUJJBYMJMN-UHFFFAOYSA-N 4-(trifluoromethyl)benzene-1,2-diamine Chemical compound NC1=CC=C(C(F)(F)F)C=C1N RQWJHUJJBYMJMN-UHFFFAOYSA-N 0.000 description 2
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
• FNFJSOFBDMCEJF-UHFFFAOYSA-N 4-[4-(4-aminophenyl)phenyl]-2,2-dimethyl-4-oxobutanoic acid Chemical compound C1=CC(C(=O)CC(C)(C)C(O)=O)=CC=C1C1=CC=C(N)C=C1 FNFJSOFBDMCEJF-UHFFFAOYSA-N 0.000 description 2
• PWOPDCSAVIMSPX-UHFFFAOYSA-N 4-bromo-2-fluoro-1-isothiocyanatobenzene Chemical compound FC1=CC(Br)=CC=C1N=C=S PWOPDCSAVIMSPX-UHFFFAOYSA-N 0.000 description 2
• GZRMNMGWNKSANY-UHFFFAOYSA-N 4-bromo-2-fluoroaniline Chemical compound NC1=CC=C(Br)C=C1F GZRMNMGWNKSANY-UHFFFAOYSA-N 0.000 description 2
• VLVCDUSVTXIWGW-UHFFFAOYSA-N 4-iodoaniline Chemical compound NC1=CC=C(I)C=C1 VLVCDUSVTXIWGW-UHFFFAOYSA-N 0.000 description 2
• CNPURSDMOWDNOQ-UHFFFAOYSA-N 4-methoxy-7h-pyrrolo[2,3-d]pyrimidin-2-amine Chemical compound COC1=NC(N)=NC2=C1C=CN2 CNPURSDMOWDNOQ-UHFFFAOYSA-N 0.000 description 2
• GWJMRTXJBNWAEL-UHFFFAOYSA-N 4-methyl-2-methylsulfonyl-1,3-benzoxazole Chemical compound CC1=CC=CC2=C1N=C(S(C)(=O)=O)O2 GWJMRTXJBNWAEL-UHFFFAOYSA-N 0.000 description 2
• YINRVZUJQJFNES-UHFFFAOYSA-N 5-chloro-2-methylsulfanyl-1,3-benzothiazole Chemical compound ClC1=CC=C2SC(SC)=NC2=C1 YINRVZUJQJFNES-UHFFFAOYSA-N 0.000 description 2
• GRNXYJLLHZIBDR-UHFFFAOYSA-N 5-chloro-2-methylsulfonyl-1,3-benzothiazole Chemical compound ClC1=CC=C2SC(S(=O)(=O)C)=NC2=C1 GRNXYJLLHZIBDR-UHFFFAOYSA-N 0.000 description 2
• DHITZHCZUWQDBD-UHFFFAOYSA-N 6-(trifluoromethoxy)-1,3-benzothiazole Chemical compound FC(F)(F)OC1=CC=C2N=CSC2=C1 DHITZHCZUWQDBD-UHFFFAOYSA-N 0.000 description 2
• BULNNISVPSQIFO-UHFFFAOYSA-N 6-(trifluoromethyl)-1,3-benzothiazole Chemical compound FC(F)(F)C1=CC=C2N=CSC2=C1 BULNNISVPSQIFO-UHFFFAOYSA-N 0.000 description 2
• KLHQGPJEYJAFOX-UHFFFAOYSA-N 6-(trifluoromethyl)-3h-1,3-benzothiazole-2-thione Chemical compound FC(F)(F)C1=CC=C2N=C(S)SC2=C1 KLHQGPJEYJAFOX-UHFFFAOYSA-N 0.000 description 2
• OYWXWHZJUSMRMU-UHFFFAOYSA-N 6-chloro-n-(2-fluoro-4-iodophenyl)-1,3-benzothiazol-2-amine Chemical compound FC1=CC(I)=CC=C1NC1=NC2=CC=C(Cl)C=C2S1 OYWXWHZJUSMRMU-UHFFFAOYSA-N 0.000 description 2
• BGSRFMFTXMPTSC-UHFFFAOYSA-N 6-fluoro-1,3-benzothiazole Chemical compound FC1=CC=C2N=CSC2=C1 BGSRFMFTXMPTSC-UHFFFAOYSA-N 0.000 description 2
• HEVDWZLPOSJJII-UHFFFAOYSA-N 6-methoxy-2-methylsulfonyl-1,3-benzothiazole Chemical compound COC1=CC=C2N=C(S(C)(=O)=O)SC2=C1 HEVDWZLPOSJJII-UHFFFAOYSA-N 0.000 description 2
• NUMDWMDMUXZMHA-UHFFFAOYSA-N 6-methyl-3h-1,3-benzoxazole-2-thione Chemical compound CC1=CC=C2NC(=S)OC2=C1 NUMDWMDMUXZMHA-UHFFFAOYSA-N 0.000 description 2
• NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
• 239000005995 Aluminium silicate Substances 0.000 description 2
• 235000003911 Arachis Nutrition 0.000 description 2
• 244000105624 Arachis hypogaea Species 0.000 description 2
• 241000416162 Astragalus gummifer Species 0.000 description 2
• 239000005711 Benzoic acid Substances 0.000 description 2
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
• QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
• 229920000623 Cellulose acetate phthalate Polymers 0.000 description 2
• RKWGIWYCVPQPMF-UHFFFAOYSA-N Chloropropamide Chemical compound CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1 RKWGIWYCVPQPMF-UHFFFAOYSA-N 0.000 description 2
• JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 2
• 229910021592 Copper(II) chloride Inorganic materials 0.000 description 2
• RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
• RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
• 229940127193 DGAT1 inhibitor Drugs 0.000 description 2
• 102000016622 Dipeptidyl Peptidase 4 Human genes 0.000 description 2
• 239000001856 Ethyl cellulose Substances 0.000 description 2
• ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
• 101000930822 Giardia intestinalis Dipeptidyl-peptidase 4 Proteins 0.000 description 2
• AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
• 229920000084 Gum arabic Polymers 0.000 description 2
• 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 2
• 241000238631 Hexapoda Species 0.000 description 2
• 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
• 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
• 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
• 229940122199 Insulin secretagogue Drugs 0.000 description 2
• 229930195725 Mannitol Natural products 0.000 description 2
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
• 241000699666 Mus <mouse, genus> Species 0.000 description 2
• MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
• WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
• UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 2
• 229910002651 NO3 Inorganic materials 0.000 description 2
• NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
• 108010016731 PPAR gamma Proteins 0.000 description 2
• 102100038825 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
• ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
• 229920002472 Starch Polymers 0.000 description 2
• 235000009470 Theobroma cacao Nutrition 0.000 description 2
• 244000299461 Theobroma cacao Species 0.000 description 2
• GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
• OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 2
• 239000007983 Tris buffer Substances 0.000 description 2
• 235000010489 acacia gum Nutrition 0.000 description 2
• 239000000205 acacia gum Substances 0.000 description 2
• 230000002378 acidificating effect Effects 0.000 description 2
• 210000000577 adipose tissue Anatomy 0.000 description 2
• 229910052783 alkali metal Inorganic materials 0.000 description 2
• 150000001350 alkyl halides Chemical class 0.000 description 2
• 235000012211 aluminium silicate Nutrition 0.000 description 2
• 150000001408 amides Chemical class 0.000 description 2
• 150000008064 anhydrides Chemical class 0.000 description 2
• 239000003963 antioxidant agent Substances 0.000 description 2
• 235000006708 antioxidants Nutrition 0.000 description 2
• 239000007900 aqueous suspension Substances 0.000 description 2
• 239000011668 ascorbic acid Substances 0.000 description 2
• 229960005070 ascorbic acid Drugs 0.000 description 2
• 239000000305 astragalus gummifer gum Substances 0.000 description 2
• 235000013871 bee wax Nutrition 0.000 description 2
• 239000012166 beeswax Substances 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 229960000686 benzalkonium chloride Drugs 0.000 description 2
• 235000010233 benzoic acid Nutrition 0.000 description 2
• 229960004365 benzoic acid Drugs 0.000 description 2
• 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
• CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
• WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
• 239000011230 binding agent Substances 0.000 description 2
• 239000012455 biphasic mixture Substances 0.000 description 2
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
• FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
• CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
• 235000013539 calcium stearate Nutrition 0.000 description 2
• 239000008116 calcium stearate Substances 0.000 description 2
• 229960001631 carbomer Drugs 0.000 description 2
• 150000001721 carbon Chemical group 0.000 description 2
• 239000001768 carboxy methyl cellulose Substances 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 230000003197 catalytic effect Effects 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 229940081734 cellulose acetate phthalate Drugs 0.000 description 2
• 238000000170 chemical ionisation mass spectrum Methods 0.000 description 2
• 239000003638 chemical reducing agent Substances 0.000 description 2
• OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
• 229960001761 chlorpropamide Drugs 0.000 description 2
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
• 238000000576 coating method Methods 0.000 description 2
• 229940110456 cocoa butter Drugs 0.000 description 2
• 235000019868 cocoa butter Nutrition 0.000 description 2
• 238000002648 combination therapy Methods 0.000 description 2
• 230000002508 compound effect Effects 0.000 description 2
• 238000007796 conventional method Methods 0.000 description 2
• 235000012343 cottonseed oil Nutrition 0.000 description 2
• 239000002385 cottonseed oil Substances 0.000 description 2
• 239000013058 crude material Substances 0.000 description 2
• 125000004122 cyclic group Chemical group 0.000 description 2
• JCWIWBWXCVGEAN-UHFFFAOYSA-L cyclopentyl(diphenyl)phosphane;dichloropalladium;iron Chemical compound [Fe].Cl[Pd]Cl.[CH]1[CH][CH][CH][C]1P(C=1C=CC=CC=1)C1=CC=CC=C1.[CH]1[CH][CH][CH][C]1P(C=1C=CC=CC=1)C1=CC=CC=C1 JCWIWBWXCVGEAN-UHFFFAOYSA-L 0.000 description 2
• 238000003745 diagnosis Methods 0.000 description 2
• 235000019700 dicalcium phosphate Nutrition 0.000 description 2
• 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 2
• LMFLGETWXFOVMQ-UHFFFAOYSA-N diethyl 2-(2-phenylethyl)propanedioate Chemical compound CCOC(=O)C(C(=O)OCC)CCC1=CC=CC=C1 LMFLGETWXFOVMQ-UHFFFAOYSA-N 0.000 description 2
• ZCZDHYJWVOWDDW-UHFFFAOYSA-N diethyl 2-[2-(4-bromophenyl)-2-oxoethyl]-2-(2-methoxyethyl)propanedioate Chemical compound CCOC(=O)C(CCOC)(C(=O)OCC)CC(=O)C1=CC=C(Br)C=C1 ZCZDHYJWVOWDDW-UHFFFAOYSA-N 0.000 description 2
• FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 2
• 229910001873 dinitrogen Inorganic materials 0.000 description 2
• ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
• 238000009826 distribution Methods 0.000 description 2
• POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
• 238000012377 drug delivery Methods 0.000 description 2
• 238000000132 electrospray ionisation Methods 0.000 description 2
• 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 239000003480 eluent Substances 0.000 description 2
• 238000010828 elution Methods 0.000 description 2
• 238000003821 enantio-separation Methods 0.000 description 2
• 230000032050 esterification Effects 0.000 description 2
• 238000005886 esterification reaction Methods 0.000 description 2
• SAAVDIFKHVENPE-UHFFFAOYSA-N ethyl 2-(2-methoxyethyl)-4-[4-(4-nitrophenyl)phenyl]-4-oxobutanoate Chemical compound C1=CC(C(=O)CC(CCOC)C(=O)OCC)=CC=C1C1=CC=C([N+]([O-])=O)C=C1 SAAVDIFKHVENPE-UHFFFAOYSA-N 0.000 description 2
• MXJHYNXUVPBCRP-UHFFFAOYSA-N ethyl 2-[2-(4-bromophenyl)-2-oxoethyl]pentanoate Chemical compound CCOC(=O)C(CCC)CC(=O)C1=CC=C(Br)C=C1 MXJHYNXUVPBCRP-UHFFFAOYSA-N 0.000 description 2
• IJYCUOAYSLFXBH-UHFFFAOYSA-N ethyl 2-[2-[4-(4-nitrophenyl)phenyl]-2-oxoethyl]pentanoate Chemical compound C1=CC(C(=O)CC(CCC)C(=O)OCC)=CC=C1C1=CC=C([N+]([O-])=O)C=C1 IJYCUOAYSLFXBH-UHFFFAOYSA-N 0.000 description 2
• SNKDSSHOMSSVPA-UHFFFAOYSA-N ethyl 4-(4-bromophenyl)-2-(2-methoxyethyl)-4-oxobutanoate Chemical compound CCOC(=O)C(CCOC)CC(=O)C1=CC=C(Br)C=C1 SNKDSSHOMSSVPA-UHFFFAOYSA-N 0.000 description 2
• MXPCDDPSXZQMAE-UHFFFAOYSA-N ethyl 4-[4-(4-nitrophenyl)phenyl]-4-oxo-2-(2-phenylethyl)butanoate Chemical compound C=1C=C(C=2C=CC(=CC=2)[N+]([O-])=O)C=CC=1C(=O)CC(C(=O)OCC)CCC1=CC=CC=C1 MXPCDDPSXZQMAE-UHFFFAOYSA-N 0.000 description 2
• 235000019325 ethyl cellulose Nutrition 0.000 description 2
• 229920001249 ethyl cellulose Polymers 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 235000019197 fats Nutrition 0.000 description 2
• 235000019253 formic acid Nutrition 0.000 description 2
• 239000012458 free base Substances 0.000 description 2
• 238000007429 general method Methods 0.000 description 2
• 239000008103 glucose Substances 0.000 description 2
• ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 230000002440 hepatic effect Effects 0.000 description 2
• 235000009200 high fat diet Nutrition 0.000 description 2
• 230000002209 hydrophobic effect Effects 0.000 description 2
• 150000001261 hydroxy acids Chemical class 0.000 description 2
• XLSMFKSTNGKWQX-UHFFFAOYSA-N hydroxyacetone Chemical compound CC(=O)CO XLSMFKSTNGKWQX-UHFFFAOYSA-N 0.000 description 2
• 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
• 229940071826 hydroxyethyl cellulose Drugs 0.000 description 2
• 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 2
• 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
• 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
• 230000001965 increasing effect Effects 0.000 description 2
• 208000015181 infectious disease Diseases 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• 239000004615 ingredient Substances 0.000 description 2
• 230000000968 intestinal effect Effects 0.000 description 2
• 230000003834 intracellular effect Effects 0.000 description 2
• 238000007918 intramuscular administration Methods 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
• NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
• 150000002596 lactones Chemical class 0.000 description 2
• 125000005647 linker group Chemical group 0.000 description 2
• 229940057995 liquid paraffin Drugs 0.000 description 2
• 235000010355 mannitol Nutrition 0.000 description 2
• 239000000594 mannitol Substances 0.000 description 2
• 238000001819 mass spectrum Methods 0.000 description 2
• 239000002609 medium Substances 0.000 description 2
• 230000004060 metabolic process Effects 0.000 description 2
• 229910052751 metal Inorganic materials 0.000 description 2
• 239000002184 metal Substances 0.000 description 2
• 150000002739 metals Chemical class 0.000 description 2
• 229960003105 metformin Drugs 0.000 description 2
• OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 description 2
• YUZNYBSCCGXRGP-GHMZBOCLSA-N methyl (1r,2r)-2-(4-bromobenzoyl)cyclobutane-1-carboxylate Chemical compound COC(=O)[C@@H]1CC[C@H]1C(=O)C1=CC=C(Br)C=C1 YUZNYBSCCGXRGP-GHMZBOCLSA-N 0.000 description 2
• XOERXLWVJMDHDW-QZTJIDSGSA-N methyl (1r,2r)-2-[4-(4-aminophenyl)benzoyl]cyclopentane-1-carboxylate Chemical compound COC(=O)[C@@H]1CCC[C@H]1C(=O)C1=CC=C(C=2C=CC(N)=CC=2)C=C1 XOERXLWVJMDHDW-QZTJIDSGSA-N 0.000 description 2
• HMVCRKFWGFQBJJ-HZPDHXFCSA-N methyl (1r,2r)-2-[4-(4-aminophenyl)benzoyl]cyclopropane-1-carboxylate Chemical compound COC(=O)[C@@H]1C[C@H]1C(=O)C1=CC=C(C=2C=CC(N)=CC=2)C=C1 HMVCRKFWGFQBJJ-HZPDHXFCSA-N 0.000 description 2
• XQCLXPWMTSKPMD-UHFFFAOYSA-N methyl 1-[2-[4-(4-nitrophenyl)phenyl]-2-oxoethyl]cyclopentane-1-carboxylate Chemical compound C=1C=C(C=2C=CC(=CC=2)[N+]([O-])=O)C=CC=1C(=O)CC1(C(=O)OC)CCCC1 XQCLXPWMTSKPMD-UHFFFAOYSA-N 0.000 description 2
• FDNNRYQUMYQRSE-UHFFFAOYSA-N methyl 2-[2-[4-(4-aminophenyl)phenyl]-2-oxoethyl]pentanoate Chemical compound C1=CC(C(=O)CC(CCC)C(=O)OC)=CC=C1C1=CC=C(N)C=C1 FDNNRYQUMYQRSE-UHFFFAOYSA-N 0.000 description 2
• IZMGUZMTPSPEBA-UHFFFAOYSA-N methyl 4-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]oxane-4-carboxylate Chemical compound CC(C)(C)OC(=O)CC1(C(=O)OC)CCOCC1 IZMGUZMTPSPEBA-UHFFFAOYSA-N 0.000 description 2
• DWFBWOLEKZIYTQ-UHFFFAOYSA-N methyl 4-[4-(4-amino-3-methylphenyl)phenyl]-2,2-dimethyl-4-oxobutanoate Chemical compound C1=CC(C(=O)CC(C)(C)C(=O)OC)=CC=C1C1=CC=C(N)C(C)=C1 DWFBWOLEKZIYTQ-UHFFFAOYSA-N 0.000 description 2
• 150000004702 methyl esters Chemical class 0.000 description 2
• LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
• 229940016286 microcrystalline cellulose Drugs 0.000 description 2
• 239000008108 microcrystalline cellulose Substances 0.000 description 2
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• PUGMCXMQHUTQOK-UHFFFAOYSA-N n-(4-bromo-2-fluorophenyl)-5-(trifluoromethyl)-1,3-benzoxazol-2-amine Chemical compound FC1=CC(Br)=CC=C1NC1=NC2=CC(C(F)(F)F)=CC=C2O1 PUGMCXMQHUTQOK-UHFFFAOYSA-N 0.000 description 2
• OULDSQVWYHKAEQ-UHFFFAOYSA-N n-(4-bromo-2-fluorophenyl)-6-(trifluoromethoxy)-1,3-benzothiazol-2-amine Chemical compound FC1=CC(Br)=CC=C1NC1=NC2=CC=C(OC(F)(F)F)C=C2S1 OULDSQVWYHKAEQ-UHFFFAOYSA-N 0.000 description 2
• ZESJSNZMSIZLKX-UHFFFAOYSA-N n-(4-iodophenyl)-6-methyl-1,3-benzothiazol-2-amine Chemical compound S1C2=CC(C)=CC=C2N=C1NC1=CC=C(I)C=C1 ZESJSNZMSIZLKX-UHFFFAOYSA-N 0.000 description 2
• 239000000346 nonvolatile oil Substances 0.000 description 2
• BNYHRGTXRPWASY-UHFFFAOYSA-N nonylsulfonylurea Chemical compound CCCCCCCCCS(=O)(=O)NC(N)=O BNYHRGTXRPWASY-UHFFFAOYSA-N 0.000 description 2
• 238000013116 obese mouse model Methods 0.000 description 2
• GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
• AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 2
• AVPKHOTUOHDTLW-UHFFFAOYSA-N oxane-4-carboxylic acid Chemical compound OC(=O)C1CCOCC1 AVPKHOTUOHDTLW-UHFFFAOYSA-N 0.000 description 2
• 125000004430 oxygen atom Chemical group O* 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 230000035515 penetration Effects 0.000 description 2
• 239000008180 pharmaceutical surfactant Substances 0.000 description 2
• 239000006187 pill Substances 0.000 description 2
• 229960005095 pioglitazone Drugs 0.000 description 2
• 229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 description 2
• 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
• 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
• 229920000053 polysorbate 80 Polymers 0.000 description 2
• 229910052700 potassium Inorganic materials 0.000 description 2
• 239000011591 potassium Substances 0.000 description 2
• 229940069328 povidone Drugs 0.000 description 2
• 229920003124 powdered cellulose Polymers 0.000 description 2
• 235000019814 powdered cellulose Nutrition 0.000 description 2
• 230000002335 preservative effect Effects 0.000 description 2
• 102000004169 proteins and genes Human genes 0.000 description 2
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
• 238000004445 quantitative analysis Methods 0.000 description 2
• 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
• 210000000664 rectum Anatomy 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 238000011160 research Methods 0.000 description 2
• 229960004586 rosiglitazone Drugs 0.000 description 2
• YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
• 229930195734 saturated hydrocarbon Natural products 0.000 description 2
• 238000010898 silica gel chromatography Methods 0.000 description 2
• 239000000344 soap Substances 0.000 description 2
• 239000012279 sodium borohydride Substances 0.000 description 2
• 229910000033 sodium borohydride Inorganic materials 0.000 description 2
• 238000010561 standard procedure Methods 0.000 description 2
• 239000008107 starch Substances 0.000 description 2
• 229940032147 starch Drugs 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 239000000758 substrate Substances 0.000 description 2
• 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
• 239000006228 supernatant Substances 0.000 description 2
• 238000003786 synthesis reaction Methods 0.000 description 2
• BNWCETAHAJSBFG-UHFFFAOYSA-N tert-butyl 2-bromoacetate Chemical compound CC(C)(C)OC(=O)CBr BNWCETAHAJSBFG-UHFFFAOYSA-N 0.000 description 2
• 238000012360 testing method Methods 0.000 description 2
• FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
• 239000002562 thickening agent Substances 0.000 description 2
• FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
• UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
• 235000010487 tragacanth Nutrition 0.000 description 2
• 239000000196 tragacanth Substances 0.000 description 2
• 229940116362 tragacanth Drugs 0.000 description 2
• 230000037317 transdermal delivery Effects 0.000 description 2
• WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 2
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
• 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
• GXPHKUHSUJUWKP-UHFFFAOYSA-N troglitazone Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)COC(C=C1)=CC=C1CC1SC(=O)NC1=O GXPHKUHSUJUWKP-UHFFFAOYSA-N 0.000 description 2
• 229960001641 troglitazone Drugs 0.000 description 2
• GXPHKUHSUJUWKP-NTKDMRAZSA-N troglitazone Natural products C([C@@]1(OC=2C(C)=C(C(=C(C)C=2CC1)O)C)C)OC(C=C1)=CC=C1C[C@H]1SC(=O)NC1=O GXPHKUHSUJUWKP-NTKDMRAZSA-N 0.000 description 2
• 229960004418 trolamine Drugs 0.000 description 2
• 241000701447 unidentified baculovirus Species 0.000 description 2
• 229940045860 white wax Drugs 0.000 description 2
• XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 2
• NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
• LSPHULWDVZXLIL-UHFFFAOYSA-N (+/-)-Camphoric acid Chemical class CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
• RQEUFEKYXDPUSK-SSDOTTSWSA-N (1R)-1-phenylethanamine Chemical compound C[C@@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-SSDOTTSWSA-N 0.000 description 1
• RQEUFEKYXDPUSK-ZETCQYMHSA-N (1S)-1-phenylethanamine Chemical compound C[C@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-ZETCQYMHSA-N 0.000 description 1
• OVZXXISOLDHARA-VXGBXAGGSA-N (1r,2r)-2-(4-bromobenzoyl)cyclohexane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCC[C@H]1C(=O)C1=CC=C(Br)C=C1 OVZXXISOLDHARA-VXGBXAGGSA-N 0.000 description 1
• VFKRRRPFLRUITM-WOJBJXKFSA-N (1r,2r)-2-[4-[3-fluoro-4-[(6-methoxy-1,3-benzothiazol-2-yl)amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound S1C2=CC(OC)=CC=C2N=C1NC(C(=C1)F)=CC=C1C(C=C1)=CC=C1C(=O)[C@@H]1CCC[C@H]1C(O)=O VFKRRRPFLRUITM-WOJBJXKFSA-N 0.000 description 1
• MSGPDRZRMKMFDB-WOJBJXKFSA-N (1r,2r)-2-[4-[3-fluoro-4-[(6-methyl-1,3-benzoxazol-2-yl)amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound O1C2=CC(C)=CC=C2N=C1NC(C(=C1)F)=CC=C1C(C=C1)=CC=C1C(=O)[C@@H]1CCC[C@H]1C(O)=O MSGPDRZRMKMFDB-WOJBJXKFSA-N 0.000 description 1
• MGUZHVMRCAENAR-WOJBJXKFSA-N (1r,2r)-2-[4-[4-[(6-chloro-1,3-benzothiazol-2-yl)amino]phenyl]benzoyl]cyclobutane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CC[C@H]1C(=O)C1=CC=C(C=2C=CC(NC=3SC4=CC(Cl)=CC=C4N=3)=CC=2)C=C1 MGUZHVMRCAENAR-WOJBJXKFSA-N 0.000 description 1
• ZZAMTZZJQQNKLK-FGZHOGPDSA-N (1r,2r)-2-[4-[4-[(6-methyl-1,3-benzothiazol-2-yl)amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound S1C2=CC(C)=CC=C2N=C1NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)[C@@H]1CCC[C@H]1C(O)=O ZZAMTZZJQQNKLK-FGZHOGPDSA-N 0.000 description 1
• OVZXXISOLDHARA-NWDGAFQWSA-N (1r,2s)-2-(4-bromobenzoyl)cyclohexane-1-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCC[C@@H]1C(=O)C1=CC=C(Br)C=C1 OVZXXISOLDHARA-NWDGAFQWSA-N 0.000 description 1
• YPSVTIOENMFRPI-QWRGUYRKSA-N (1s,3s)-3-(4-bromobenzoyl)cyclohexane-1-carboxylic acid Chemical compound C1[C@@H](C(=O)O)CCC[C@@H]1C(=O)C1=CC=C(Br)C=C1 YPSVTIOENMFRPI-QWRGUYRKSA-N 0.000 description 1
• FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
• QIQPUTGABWFOAQ-UHFFFAOYSA-N (2-chloro-1,3-benzothiazol-7-yl)-morpholin-4-ylmethanone Chemical compound C=12SC(Cl)=NC2=CC=CC=1C(=O)N1CCOCC1 QIQPUTGABWFOAQ-UHFFFAOYSA-N 0.000 description 1
• PYGGEOFNOAVTCT-UHFFFAOYSA-N (2-chloro-1,3-thiazol-4-yl)methanol Chemical compound OCC1=CSC(Cl)=N1 PYGGEOFNOAVTCT-UHFFFAOYSA-N 0.000 description 1
• SFUIGUOONHIVLG-UHFFFAOYSA-N (2-nitrophenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1[N+]([O-])=O SFUIGUOONHIVLG-UHFFFAOYSA-N 0.000 description 1
• QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
• XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
• NVXFXLSOGLFXKQ-JMSVASOKSA-N (2s)-1-[(2r,4r)-5-ethoxy-2,4-dimethyl-5-oxopentanoyl]-2,3-dihydroindole-2-carboxylic acid Chemical compound C1=CC=C2N(C(=O)[C@H](C)C[C@@H](C)C(=O)OCC)[C@H](C(O)=O)CC2=C1 NVXFXLSOGLFXKQ-JMSVASOKSA-N 0.000 description 1
• ZGGHKIMDNBDHJB-NRFPMOEYSA-M (3R,5S)-fluvastatin sodium Chemical compound [Na+].C12=CC=CC=C2N(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 ZGGHKIMDNBDHJB-NRFPMOEYSA-M 0.000 description 1
• QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
• VDURJIGQVKMELT-UHFFFAOYSA-N (4-methylphenyl) thiocyanate Chemical compound CC1=CC=C(SC#N)C=C1 VDURJIGQVKMELT-UHFFFAOYSA-N 0.000 description 1
• CNVRALIOWLIHEP-UHFFFAOYSA-N (5,5-dimethyloxolan-3-yl)methanol Chemical compound CC1(C)CC(CO)CO1 CNVRALIOWLIHEP-UHFFFAOYSA-N 0.000 description 1
• YXIWHUQXZSMYRE-UHFFFAOYSA-N 1,3-benzothiazole-2-thiol Chemical compound C1=CC=C2SC(S)=NC2=C1 YXIWHUQXZSMYRE-UHFFFAOYSA-N 0.000 description 1
• 125000004227 1,3-benzoxazol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N=C(*)OC2=C1[H] 0.000 description 1
• QWSCWZNMKKWYDD-UHFFFAOYSA-N 1-(4-bromophenyl)-3-(2-hydroxy-5-methylphenyl)thiourea Chemical compound CC1=CC=C(O)C(NC(=S)NC=2C=CC(Br)=CC=2)=C1 QWSCWZNMKKWYDD-UHFFFAOYSA-N 0.000 description 1
• PVLIRTAXXPPHCJ-UHFFFAOYSA-N 1-benzyl-2-chlorobenzimidazole Chemical compound ClC1=NC2=CC=CC=C2N1CC1=CC=CC=C1 PVLIRTAXXPPHCJ-UHFFFAOYSA-N 0.000 description 1
• MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 1
• WSULSMOGMLRGKU-UHFFFAOYSA-N 1-bromooctadecane Chemical compound CCCCCCCCCCCCCCCCCCBr WSULSMOGMLRGKU-UHFFFAOYSA-N 0.000 description 1
• VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical compound CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 description 1
• VUQPJRPDRDVQMN-UHFFFAOYSA-N 1-chlorooctadecane Chemical compound CCCCCCCCCCCCCCCCCCCl VUQPJRPDRDVQMN-UHFFFAOYSA-N 0.000 description 1
• HNEGJTWNOOWEMH-UHFFFAOYSA-N 1-fluoropropane Chemical group [CH2]CCF HNEGJTWNOOWEMH-UHFFFAOYSA-N 0.000 description 1
• ZNJOCVLVYVOUGB-UHFFFAOYSA-N 1-iodooctadecane Chemical compound CCCCCCCCCCCCCCCCCCI ZNJOCVLVYVOUGB-UHFFFAOYSA-N 0.000 description 1
• JUIXCTTUMZKIDG-UHFFFAOYSA-N 11,12,13-trihydroxytricosane-10,14-dione Chemical compound CCCCCCCCCC(=O)C(O)C(O)C(O)C(=O)CCCCCCCCC JUIXCTTUMZKIDG-UHFFFAOYSA-N 0.000 description 1
• HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
• GUSVHVVOABZHAH-OPZWKQDFSA-N 1aw8p77hkj Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]([C@]1(OC[C@H](C)CC1)O5)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GUSVHVVOABZHAH-OPZWKQDFSA-N 0.000 description 1
• 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
• JJWANONAOYNRME-UHFFFAOYSA-N 2,4-dichloro-1,3-benzothiazole Chemical compound C1=CC=C2SC(Cl)=NC2=C1Cl JJWANONAOYNRME-UHFFFAOYSA-N 0.000 description 1
• LLIARSREYVCQHL-UHFFFAOYSA-N 2,6-dichloro-1h-benzimidazole Chemical compound C1=C(Cl)C=C2NC(Cl)=NC2=C1 LLIARSREYVCQHL-UHFFFAOYSA-N 0.000 description 1
• SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
• FZEDQMJQPLKXRH-UHFFFAOYSA-N 2-(4-chlorophenoxy)-2-methyl-n-(6-methyl-1,3-benzothiazol-2-yl)propanamide Chemical group S1C2=CC(C)=CC=C2N=C1NC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 FZEDQMJQPLKXRH-UHFFFAOYSA-N 0.000 description 1
• KUXGUCNZFCVULO-UHFFFAOYSA-N 2-(4-nonylphenoxy)ethanol Chemical compound CCCCCCCCCC1=CC=C(OCCO)C=C1 KUXGUCNZFCVULO-UHFFFAOYSA-N 0.000 description 1
• TWIPCCMPIAFOKZ-UHFFFAOYSA-N 2-(trifluoromethyl)-1,3-benzothiazole Chemical compound C1=CC=C2SC(C(F)(F)F)=NC2=C1 TWIPCCMPIAFOKZ-UHFFFAOYSA-N 0.000 description 1
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
• XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
• NWCBWXBZVKJIHM-UHFFFAOYSA-N 2-[2-(4-bromophenyl)-2-oxoethyl]-2-propylpropanedioic acid Chemical compound CCCC(C(O)=O)(C(O)=O)CC(=O)C1=CC=C(Br)C=C1 NWCBWXBZVKJIHM-UHFFFAOYSA-N 0.000 description 1
• HNLXNOZHXNSSPN-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCOCCOCCOCCO)C=C1 HNLXNOZHXNSSPN-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• HYDYRAMHCBQLFV-UHFFFAOYSA-N 2-[4-[4-[(5-fluoro-1,3-benzoxazol-2-yl)amino]phenyl]benzoyl]cyclopentane-1-carboxylic acid Chemical compound OC(=O)C1CCCC1C(=O)C1=CC=C(C=2C=CC(NC=3OC4=CC=C(F)C=C4N=3)=CC=2)C=C1 HYDYRAMHCBQLFV-UHFFFAOYSA-N 0.000 description 1
• HCPJEHJGFKWRFM-UHFFFAOYSA-N 2-amino-5-methylphenol Chemical compound CC1=CC=C(N)C(O)=C1 HCPJEHJGFKWRFM-UHFFFAOYSA-N 0.000 description 1
• ZMXYNJXDULEQCK-UHFFFAOYSA-N 2-amino-p-cresol Chemical compound CC1=CC=C(O)C(N)=C1 ZMXYNJXDULEQCK-UHFFFAOYSA-N 0.000 description 1
• FKJSFKCZZIXQIP-UHFFFAOYSA-N 2-bromo-1-(4-bromophenyl)ethanone Chemical compound BrCC(=O)C1=CC=C(Br)C=C1 FKJSFKCZZIXQIP-UHFFFAOYSA-N 0.000 description 1
• DGJJTJCIKQHVHT-UHFFFAOYSA-N 2-chloro-1,3-benzothiazole-5-carbonitrile Chemical compound N#CC1=CC=C2SC(Cl)=NC2=C1 DGJJTJCIKQHVHT-UHFFFAOYSA-N 0.000 description 1
• UQSDIXGADTUHOS-UHFFFAOYSA-N 2-chloro-1,3-benzothiazole-5-carboxamide Chemical compound NC(=O)C1=CC=C2SC(Cl)=NC2=C1 UQSDIXGADTUHOS-UHFFFAOYSA-N 0.000 description 1
• DHBTVASVKVLZBJ-UHFFFAOYSA-N 2-chloro-1,3-benzothiazole-6-carbonitrile Chemical compound C1=C(C#N)C=C2SC(Cl)=NC2=C1 DHBTVASVKVLZBJ-UHFFFAOYSA-N 0.000 description 1
• BBVQDWDBTWSGHQ-UHFFFAOYSA-N 2-chloro-1,3-benzoxazole Chemical compound C1=CC=C2OC(Cl)=NC2=C1 BBVQDWDBTWSGHQ-UHFFFAOYSA-N 0.000 description 1
• UENGBOCGGKLVJJ-UHFFFAOYSA-N 2-chloro-1-(2,4-difluorophenyl)ethanone Chemical compound FC1=CC=C(C(=O)CCl)C(F)=C1 UENGBOCGGKLVJJ-UHFFFAOYSA-N 0.000 description 1
• FBJWXQWZWIISCG-UHFFFAOYSA-N 2-chloro-1-cyclopropylbenzimidazole Chemical compound ClC1=NC2=CC=CC=C2N1C1CC1 FBJWXQWZWIISCG-UHFFFAOYSA-N 0.000 description 1
• IROJYPSJGGDBCD-UHFFFAOYSA-N 2-chloro-1-ethylbenzimidazole Chemical compound C1=CC=C2N(CC)C(Cl)=NC2=C1 IROJYPSJGGDBCD-UHFFFAOYSA-N 0.000 description 1
• MAVNZJBNKICAAC-UHFFFAOYSA-N 2-chloro-1-propan-2-ylbenzimidazole Chemical compound C1=CC=C2N(C(C)C)C(Cl)=NC2=C1 MAVNZJBNKICAAC-UHFFFAOYSA-N 0.000 description 1
• WDWQXEUJKGYNPZ-UHFFFAOYSA-N 2-chloro-3h-benzimidazole-5-carbonitrile Chemical compound N#CC1=CC=C2NC(Cl)=NC2=C1 WDWQXEUJKGYNPZ-UHFFFAOYSA-N 0.000 description 1
• UTMPHXLKDRAIDK-UHFFFAOYSA-N 2-chloro-4,5-dimethyl-1,3-thiazole Chemical compound CC=1N=C(Cl)SC=1C UTMPHXLKDRAIDK-UHFFFAOYSA-N 0.000 description 1
• MBBUTABXEITVNY-UHFFFAOYSA-N 2-chloro-4-(trifluoromethyl)aniline Chemical compound NC1=CC=C(C(F)(F)F)C=C1Cl MBBUTABXEITVNY-UHFFFAOYSA-N 0.000 description 1
• SYDUUJIIXIOTQT-UHFFFAOYSA-N 2-chloro-4-methyl-1,3-thiazole Chemical compound CC1=CSC(Cl)=N1 SYDUUJIIXIOTQT-UHFFFAOYSA-N 0.000 description 1
• XODBBWCMOHPBMI-UHFFFAOYSA-N 2-chloro-5,6-dimethyl-1,3-benzothiazole Chemical compound C1=C(C)C(C)=CC2=C1SC(Cl)=N2 XODBBWCMOHPBMI-UHFFFAOYSA-N 0.000 description 1
• UMPCQBBRKCVELL-UHFFFAOYSA-N 2-chloro-5,7-dimethyl-1,3-benzothiazole Chemical compound CC1=CC(C)=C2SC(Cl)=NC2=C1 UMPCQBBRKCVELL-UHFFFAOYSA-N 0.000 description 1
• VYLUUPQJTOZHCP-UHFFFAOYSA-N 2-chloro-5-(2,4-dimethylphenyl)-1,3-thiazole Chemical compound CC1=CC(C)=CC=C1C1=CN=C(Cl)S1 VYLUUPQJTOZHCP-UHFFFAOYSA-N 0.000 description 1
• GJTJPGDADZEIIP-UHFFFAOYSA-N 2-chloro-5-(4-methoxyphenyl)-1,3-thiazole Chemical compound C1=CC(OC)=CC=C1C1=CN=C(Cl)S1 GJTJPGDADZEIIP-UHFFFAOYSA-N 0.000 description 1
• YVCPQBWTMDEDQC-UHFFFAOYSA-N 2-chloro-5-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=CN=C(Cl)S1 YVCPQBWTMDEDQC-UHFFFAOYSA-N 0.000 description 1
• BKVFRKXBHAJNEA-UHFFFAOYSA-N 2-chloro-5-(4-propan-2-ylphenyl)-1,3-thiazole Chemical compound C1=CC(C(C)C)=CC=C1C1=CN=C(Cl)S1 BKVFRKXBHAJNEA-UHFFFAOYSA-N 0.000 description 1
• VKTTYIXIDXWHKW-UHFFFAOYSA-N 2-chloro-5-(trifluoromethyl)aniline Chemical compound NC1=CC(C(F)(F)F)=CC=C1Cl VKTTYIXIDXWHKW-UHFFFAOYSA-N 0.000 description 1
• ZOHVWGDSBHMZLO-UHFFFAOYSA-N 2-chloro-5-fluoro-1-methylbenzimidazole Chemical compound FC1=CC=C2N(C)C(Cl)=NC2=C1 ZOHVWGDSBHMZLO-UHFFFAOYSA-N 0.000 description 1
• VMDNMMTVTJNBAI-UHFFFAOYSA-N 2-chloro-5-fluoro-1-propan-2-ylbenzimidazole Chemical compound FC1=CC=C2N(C(C)C)C(Cl)=NC2=C1 VMDNMMTVTJNBAI-UHFFFAOYSA-N 0.000 description 1
• UUERHMFUYYXLRE-UHFFFAOYSA-N 2-chloro-5-methoxy-1,3-benzothiazole Chemical compound COC1=CC=C2SC(Cl)=NC2=C1 UUERHMFUYYXLRE-UHFFFAOYSA-N 0.000 description 1
• PCENMVBPJDIUPD-UHFFFAOYSA-N 2-chloro-5-methylsulfonyl-1,3-benzoxazole Chemical compound CS(=O)(=O)C1=CC=C2OC(Cl)=NC2=C1 PCENMVBPJDIUPD-UHFFFAOYSA-N 0.000 description 1
• CZQXWSPZVZKNRM-UHFFFAOYSA-N 2-chloro-6-(trifluoromethyl)-1h-benzimidazole Chemical compound FC(F)(F)C1=CC=C2N=C(Cl)NC2=C1 CZQXWSPZVZKNRM-UHFFFAOYSA-N 0.000 description 1
• OJRYLNVGOPEAEP-UHFFFAOYSA-N 2-chloro-6-ethoxy-1,3-benzothiazole Chemical compound CCOC1=CC=C2N=C(Cl)SC2=C1 OJRYLNVGOPEAEP-UHFFFAOYSA-N 0.000 description 1
• UZIXQYXXJBMILL-UHFFFAOYSA-N 2-chloro-6-fluoro-1h-benzimidazole Chemical compound FC1=CC=C2NC(Cl)=NC2=C1 UZIXQYXXJBMILL-UHFFFAOYSA-N 0.000 description 1
• FVUFTABOJFRHSU-UHFFFAOYSA-N 2-chloro-6-methoxy-1,3-benzothiazole Chemical compound COC1=CC=C2N=C(Cl)SC2=C1 FVUFTABOJFRHSU-UHFFFAOYSA-N 0.000 description 1
• FMDGYQOERIOABX-UHFFFAOYSA-N 2-chloro-6-methoxy-1h-benzimidazole Chemical compound COC1=CC=C2N=C(Cl)NC2=C1 FMDGYQOERIOABX-UHFFFAOYSA-N 0.000 description 1
• PAKSGYIFUVNJQF-UHFFFAOYSA-N 2-chloro-6-methyl-1,3-benzothiazole Chemical compound CC1=CC=C2N=C(Cl)SC2=C1 PAKSGYIFUVNJQF-UHFFFAOYSA-N 0.000 description 1
• SMDXMKNQGRCNRE-UHFFFAOYSA-N 2-chloro-6-methylsulfonyl-1,3-benzothiazole Chemical compound CS(=O)(=O)C1=CC=C2N=C(Cl)SC2=C1 SMDXMKNQGRCNRE-UHFFFAOYSA-N 0.000 description 1
• KUCSJGBXJBQHNI-UHFFFAOYSA-N 2-chloro-6-nitro-1,3-benzothiazole Chemical compound [O-][N+](=O)C1=CC=C2N=C(Cl)SC2=C1 KUCSJGBXJBQHNI-UHFFFAOYSA-N 0.000 description 1
• GWSMACGSFHRVFA-UHFFFAOYSA-N 2-chloro-6-nitro-1h-benzimidazole Chemical compound [O-][N+](=O)C1=CC=C2N=C(Cl)NC2=C1 GWSMACGSFHRVFA-UHFFFAOYSA-N 0.000 description 1
• VDXJKIZWLVTCGY-UHFFFAOYSA-N 2-chloro-6-propan-2-yloxy-1,3-benzothiazole Chemical compound CC(C)OC1=CC=C2N=C(Cl)SC2=C1 VDXJKIZWLVTCGY-UHFFFAOYSA-N 0.000 description 1
• YMHRRUZNFXSHJP-UHFFFAOYSA-N 2-chloro-7-methoxy-1-propan-2-ylbenzimidazole Chemical compound COC1=CC=CC2=C1N(C(C)C)C(Cl)=N2 YMHRRUZNFXSHJP-UHFFFAOYSA-N 0.000 description 1
• JQAZAEWPYOTTHC-UHFFFAOYSA-N 2-chloro-n,n-dimethyl-1,3-benzothiazole-5-carboxamide Chemical compound CN(C)C(=O)C1=CC=C2SC(Cl)=NC2=C1 JQAZAEWPYOTTHC-UHFFFAOYSA-N 0.000 description 1
• ATDHFHVYYBXALA-UHFFFAOYSA-N 2-chloro-n,n-dimethyl-1,3-benzothiazole-6-carboxamide Chemical compound CN(C)C(=O)C1=CC=C2N=C(Cl)SC2=C1 ATDHFHVYYBXALA-UHFFFAOYSA-N 0.000 description 1
• IKSHDFJHYUOITN-UHFFFAOYSA-N 2-chloro-n-(2-hydroxyethyl)-1,3-benzothiazole-5-carboxamide Chemical compound OCCNC(=O)C1=CC=C2SC(Cl)=NC2=C1 IKSHDFJHYUOITN-UHFFFAOYSA-N 0.000 description 1
• YAVLGJPROLEPEH-UHFFFAOYSA-N 2-chloro-n-(2-hydroxyethyl)-1,3-benzothiazole-6-carboxamide Chemical compound OCCNC(=O)C1=CC=C2N=C(Cl)SC2=C1 YAVLGJPROLEPEH-UHFFFAOYSA-N 0.000 description 1
• JGYFPHUTWCOUCA-UHFFFAOYSA-N 2-chloro-n-ethyl-1,3-benzothiazole-5-carboxamide Chemical compound CCNC(=O)C1=CC=C2SC(Cl)=NC2=C1 JGYFPHUTWCOUCA-UHFFFAOYSA-N 0.000 description 1
• QVDUPZYMJUTLNS-UHFFFAOYSA-N 2-chloro-n-methyl-1,3-benzothiazole-6-carboxamide Chemical compound CNC(=O)C1=CC=C2N=C(Cl)SC2=C1 QVDUPZYMJUTLNS-UHFFFAOYSA-N 0.000 description 1
• BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
• WROUWQQRXUBECT-UHFFFAOYSA-N 2-ethylacrylic acid Chemical compound CCC(=C)C(O)=O WROUWQQRXUBECT-UHFFFAOYSA-N 0.000 description 1
• JNQVLKWNKVMFBN-UHFFFAOYSA-N 2-hydroxy-n,n-dimethylacetamide Chemical compound CN(C)C(=O)CO JNQVLKWNKVMFBN-UHFFFAOYSA-N 0.000 description 1
• UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 description 1
• KYGFHAUBFNTXFK-UHFFFAOYSA-N 2-methoxycarbonylcyclopentane-1-carboxylic acid Chemical compound COC(=O)C1CCCC1C(O)=O KYGFHAUBFNTXFK-UHFFFAOYSA-N 0.000 description 1
• JNFFNBPSXQIOQH-UHFFFAOYSA-N 2-methylsulfanyl-1,3-benzothiazole-5-carbonitrile Chemical compound N#CC1=CC=C2SC(SC)=NC2=C1 JNFFNBPSXQIOQH-UHFFFAOYSA-N 0.000 description 1
• PZMMECZMUFZGLD-UHFFFAOYSA-N 2-methylsulfonyl-1,3-benzoxazole Chemical compound C1=CC=C2OC(S(=O)(=O)C)=NC2=C1 PZMMECZMUFZGLD-UHFFFAOYSA-N 0.000 description 1
• OTHVXMXSRLMTIP-UHFFFAOYSA-N 2-methylsulfonyl-5,6,7,8-tetrahydrobenzo[f][1,3]benzoxazole Chemical compound C1CCCC2=C1C=C1N=C(S(=O)(=O)C)OC1=C2 OTHVXMXSRLMTIP-UHFFFAOYSA-N 0.000 description 1
• ZSSIUWGWVAKXBS-UHFFFAOYSA-N 2-methylsulfonyl-5-propan-2-yl-1,3-benzoxazole Chemical compound CC(C)C1=CC=C2OC(S(C)(=O)=O)=NC2=C1 ZSSIUWGWVAKXBS-UHFFFAOYSA-N 0.000 description 1
• LRRCZUSGIWVZRS-UHFFFAOYSA-N 2-methylsulfonyl-5-propyl-1,3-benzoxazole Chemical compound CCCC1=CC=C2OC(S(C)(=O)=O)=NC2=C1 LRRCZUSGIWVZRS-UHFFFAOYSA-N 0.000 description 1
• 229940080296 2-naphthalenesulfonate Drugs 0.000 description 1
• XZEDEVRSUANQEM-UHFFFAOYSA-N 2-nitro-4-(trifluoromethyl)phenol Chemical compound OC1=CC=C(C(F)(F)F)C=C1[N+]([O-])=O XZEDEVRSUANQEM-UHFFFAOYSA-N 0.000 description 1
• PWEKCCPUQNOPFO-UHFFFAOYSA-N 2-oxaspiro[3.3]heptane-1,3-dione Chemical compound O=C1OC(=O)C11CCC1 PWEKCCPUQNOPFO-UHFFFAOYSA-N 0.000 description 1
• QQVNJGSZBSTGBJ-UHFFFAOYSA-N 2-oxoethyl thiocyanate Chemical compound O=CCSC#N QQVNJGSZBSTGBJ-UHFFFAOYSA-N 0.000 description 1
• WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical compound BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 description 1
• ZNGINKJHQQQORD-UHFFFAOYSA-N 2-trimethylsilylethanol Chemical compound C[Si](C)(C)CCO ZNGINKJHQQQORD-UHFFFAOYSA-N 0.000 description 1
• JEFFSVFEDBUHLO-VSGBNLITSA-N 2-trimethylsilylethyl (1r,2r)-2-[4-[4-[(5-methyl-1,3-benzoxazol-2-yl)amino]phenyl]benzoyl]cyclohexane-1-carboxylate Chemical compound N=1C2=CC(C)=CC=C2OC=1NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)[C@@H]1CCCC[C@H]1C(=O)OCC[Si](C)(C)C JEFFSVFEDBUHLO-VSGBNLITSA-N 0.000 description 1
• ACJPFLIEHGFXGP-UHFFFAOYSA-N 3,3-dimethyloxolane-2,5-dione Chemical compound CC1(C)CC(=O)OC1=O ACJPFLIEHGFXGP-UHFFFAOYSA-N 0.000 description 1
• KQOIBXZRCYFZSO-UHFFFAOYSA-N 3,5-difluoroaniline Chemical compound NC1=CC(F)=CC(F)=C1 KQOIBXZRCYFZSO-UHFFFAOYSA-N 0.000 description 1
• DFAOJCBILNQLGC-UHFFFAOYSA-N 3-[4-[4-[(6-chloro-1,3-benzothiazol-2-yl)amino]phenyl]benzoyl]cyclohexane-1-carboxylic acid Chemical compound C1C(C(=O)O)CCCC1C(=O)C1=CC=C(C=2C=CC(NC=3SC4=CC(Cl)=CC=C4N=3)=CC=2)C=C1 DFAOJCBILNQLGC-UHFFFAOYSA-N 0.000 description 1
• ZRPLANDPDWYOMZ-UHFFFAOYSA-N 3-cyclopentylpropionic acid Chemical compound OC(=O)CCC1CCCC1 ZRPLANDPDWYOMZ-UHFFFAOYSA-N 0.000 description 1
• ZRMYHUFDVLRYPN-UHFFFAOYSA-N 3-oxabicyclo[3.1.0]hexane-2,4-dione Chemical compound O=C1OC(=O)C2CC12 ZRMYHUFDVLRYPN-UHFFFAOYSA-N 0.000 description 1
• XMIIGOLPHOKFCH-UHFFFAOYSA-M 3-phenylpropionate Chemical compound [O-]C(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-M 0.000 description 1
• ZDTNHRWWURISAA-UHFFFAOYSA-N 4',5'-dibromo-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C(Br)=C1OC1=C(Br)C(O)=CC=C21 ZDTNHRWWURISAA-UHFFFAOYSA-N 0.000 description 1
• NMSRALOLNIBERV-UHFFFAOYSA-N 4,5,6,6a-tetrahydro-3ah-cyclopenta[c]furan-1,3-dione Chemical compound C1CCC2C(=O)OC(=O)C21 NMSRALOLNIBERV-UHFFFAOYSA-N 0.000 description 1
• PPWRHKISAQTCCG-UHFFFAOYSA-N 4,5-difluorobenzene-1,2-diamine Chemical compound NC1=CC(F)=C(F)C=C1N PPWRHKISAQTCCG-UHFFFAOYSA-N 0.000 description 1
• DDKKXSCVPKDRRS-UHFFFAOYSA-N 4,6-difluoro-1,3-benzothiazol-2-amine Chemical compound C1=C(F)C=C2SC(N)=NC2=C1F DDKKXSCVPKDRRS-UHFFFAOYSA-N 0.000 description 1
• SWLAMJPTOQZTAE-UHFFFAOYSA-N 4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]benzoic acid Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(C(O)=O)C=C1 SWLAMJPTOQZTAE-UHFFFAOYSA-N 0.000 description 1
• ADYWBFBXUJFLII-UHFFFAOYSA-N 4-bromo-n-fluoroaniline Chemical compound FNC1=CC=C(Br)C=C1 ADYWBFBXUJFLII-UHFFFAOYSA-N 0.000 description 1
• WDFQBORIUYODSI-UHFFFAOYSA-N 4-bromoaniline Chemical compound NC1=CC=C(Br)C=C1 WDFQBORIUYODSI-UHFFFAOYSA-N 0.000 description 1
• ABEUJUYEUCCZQF-UHFFFAOYSA-N 4-chloro-2-methoxy-1-nitrobenzene Chemical compound COC1=CC(Cl)=CC=C1[N+]([O-])=O ABEUJUYEUCCZQF-UHFFFAOYSA-N 0.000 description 1
• HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
• IAMNVCJECQWBLZ-UHFFFAOYSA-N 4-hydroxy-2-methylacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1C IAMNVCJECQWBLZ-UHFFFAOYSA-N 0.000 description 1
• 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 description 1
• GRIATXVEXOFBGO-UHFFFAOYSA-N 4-methyl-1,3-benzothiazol-2-amine Chemical compound CC1=CC=CC2=C1N=C(N)S2 GRIATXVEXOFBGO-UHFFFAOYSA-N 0.000 description 1
• PIUXNZAIHQAHBY-UHFFFAOYSA-N 4-methyl-1,3-benzothiazole Chemical compound CC1=CC=CC2=C1N=CS2 PIUXNZAIHQAHBY-UHFFFAOYSA-N 0.000 description 1
• IAYQNPPZFVAZLY-UHFFFAOYSA-N 5,6-difluoro-1h-benzimidazole Chemical compound C1=C(F)C(F)=CC2=C1NC=N2 IAYQNPPZFVAZLY-UHFFFAOYSA-N 0.000 description 1
• CYGNGQFYMOPDTO-UHFFFAOYSA-N 5,6-dimethyl-2-methylsulfonyl-1,3-benzoxazole Chemical compound C1=C(C)C(C)=CC2=C1OC(S(C)(=O)=O)=N2 CYGNGQFYMOPDTO-UHFFFAOYSA-N 0.000 description 1
• SJCQCBHFYJXBKB-UHFFFAOYSA-N 5,7-difluoro-1,3-benzothiazole Chemical compound FC1=CC(F)=C2SC=NC2=C1 SJCQCBHFYJXBKB-UHFFFAOYSA-N 0.000 description 1
• MVDXXGIBARMXSA-PYUWXLGESA-N 5-[[(2r)-2-benzyl-3,4-dihydro-2h-chromen-6-yl]methyl]-1,3-thiazolidine-2,4-dione Chemical compound S1C(=O)NC(=O)C1CC1=CC=C(O[C@@H](CC=2C=CC=CC=2)CC2)C2=C1 MVDXXGIBARMXSA-PYUWXLGESA-N 0.000 description 1
• NKYDKCVZNMNZCM-UHFFFAOYSA-N 5-chloro-3h-1,3-benzothiazole-2-thione Chemical compound ClC1=CC=C2SC(S)=NC2=C1 NKYDKCVZNMNZCM-UHFFFAOYSA-N 0.000 description 1
• ANEKYSBZODRVRB-UHFFFAOYSA-N 5-fluoro-1,3-benzothiazole Chemical compound FC1=CC=C2SC=NC2=C1 ANEKYSBZODRVRB-UHFFFAOYSA-N 0.000 description 1
• XKOMWVRIZHWDMS-UHFFFAOYSA-N 5-fluoro-2-methylsulfonyl-1,3-benzoxazole Chemical compound FC1=CC=C2OC(S(=O)(=O)C)=NC2=C1 XKOMWVRIZHWDMS-UHFFFAOYSA-N 0.000 description 1
• JXMNNMYCHOHEDG-UHFFFAOYSA-N 5-fluoro-3h-1,3-benzothiazole-2-thione Chemical compound FC1=CC=C2SC(=S)NC2=C1 JXMNNMYCHOHEDG-UHFFFAOYSA-N 0.000 description 1
• HVCQEZZVIOIAHE-UHFFFAOYSA-N 5-methyl-2-methylsulfonyl-1,3-benzoxazole Chemical compound CC1=CC=C2OC(S(C)(=O)=O)=NC2=C1 HVCQEZZVIOIAHE-UHFFFAOYSA-N 0.000 description 1
• WEDYEBJLWMPPOK-UHFFFAOYSA-N 6-(trifluoromethyl)-1,3-benzothiazol-2-amine Chemical compound C1=C(C(F)(F)F)C=C2SC(N)=NC2=C1 WEDYEBJLWMPPOK-UHFFFAOYSA-N 0.000 description 1
• KOZFQNYQFLQFIC-UHFFFAOYSA-N 6-butoxy-2-chloro-1,3-benzothiazole Chemical compound CCCCOC1=CC=C2N=C(Cl)SC2=C1 KOZFQNYQFLQFIC-UHFFFAOYSA-N 0.000 description 1
• UGSLNABKTMJMRX-UHFFFAOYSA-N 6-chloro-2-methylsulfonyl-1,3-benzoxazole Chemical compound C1=C(Cl)C=C2OC(S(=O)(=O)C)=NC2=C1 UGSLNABKTMJMRX-UHFFFAOYSA-N 0.000 description 1
• AOVNBJLVSLQCTM-UHFFFAOYSA-N 6-fluoro-2-methylsulfonyl-1,3-benzoxazole Chemical compound C1=C(F)C=C2OC(S(=O)(=O)C)=NC2=C1 AOVNBJLVSLQCTM-UHFFFAOYSA-N 0.000 description 1
• AHOIGFLSEXUWNV-UHFFFAOYSA-N 6-methoxy-1,3-benzothiazole Chemical compound COC1=CC=C2N=CSC2=C1 AHOIGFLSEXUWNV-UHFFFAOYSA-N 0.000 description 1
• FDTWAOHFAVKRSO-UHFFFAOYSA-N 6-methoxy-2-methylsulfonyl-1,3-benzoxazole Chemical compound COC1=CC=C2N=C(S(C)(=O)=O)OC2=C1 FDTWAOHFAVKRSO-UHFFFAOYSA-N 0.000 description 1
• SZWNDAUMBWLYOQ-UHFFFAOYSA-N 6-methylbenzoxazole Chemical compound CC1=CC=C2N=COC2=C1 SZWNDAUMBWLYOQ-UHFFFAOYSA-N 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• DJQOOSBJCLSSEY-UHFFFAOYSA-N Acipimox Chemical compound CC1=CN=C(C(O)=O)C=[N+]1[O-] DJQOOSBJCLSSEY-UHFFFAOYSA-N 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
• ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
• 108010011485 Aspartame Proteins 0.000 description 1
• XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
• XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• 239000002028 Biomass Substances 0.000 description 1
• 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
• 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
• NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
• FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
• 239000002083 C09CA01 - Losartan Substances 0.000 description 1
• 239000004072 C09CA03 - Valsartan Substances 0.000 description 1
• 239000002947 C09CA04 - Irbesartan Substances 0.000 description 1
• FTUDXTOVVWAXDB-NKFKGCMQSA-N CCOC(/C(/CCc1ccccc1)=C\C(C(CC1)=CC=C1C(CC1)=CC=C1N)=O)=O Chemical compound CCOC(/C(/CCc1ccccc1)=C\C(C(CC1)=CC=C1C(CC1)=CC=C1N)=O)=O FTUDXTOVVWAXDB-NKFKGCMQSA-N 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 108091006146 Channels Proteins 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• 229920001268 Cholestyramine Polymers 0.000 description 1
• 208000017667 Chronic Disease Diseases 0.000 description 1
• 108010004103 Chylomicrons Proteins 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 229920002911 Colestipol Polymers 0.000 description 1
• 206010052360 Colorectal adenocarcinoma Diseases 0.000 description 1
• 102100025892 Complement C1q tumor necrosis factor-related protein 1 Human genes 0.000 description 1
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
• RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
• NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical class C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
• ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
• IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
• LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 108010061435 Enalapril Proteins 0.000 description 1
• 108090000371 Esterases Proteins 0.000 description 1
• IYXGSMUGOJNHAZ-UHFFFAOYSA-N Ethyl malonate Chemical class CCOC(=O)CC(=O)OCC IYXGSMUGOJNHAZ-UHFFFAOYSA-N 0.000 description 1
• 239000000940 FEMA 2235 Substances 0.000 description 1
• 238000005863 Friedel-Crafts acylation reaction Methods 0.000 description 1
• 230000005526 G1 to G0 transition Effects 0.000 description 1
• HEMJJKBWTPKOJG-UHFFFAOYSA-N Gemfibrozil Chemical compound CC1=CC=C(C)C(OCCCC(C)(C)C(O)=O)=C1 HEMJJKBWTPKOJG-UHFFFAOYSA-N 0.000 description 1
• 102000051325 Glucagon Human genes 0.000 description 1
• 108060003199 Glucagon Proteins 0.000 description 1
• FAEKWTJYAYMJKF-QHCPKHFHSA-N GlucoNorm Chemical compound C1=C(C(O)=O)C(OCC)=CC(CC(=O)N[C@@H](CC(C)C)C=2C(=CC=CC=2)N2CCCCC2)=C1 FAEKWTJYAYMJKF-QHCPKHFHSA-N 0.000 description 1
• 244000068988 Glycine max Species 0.000 description 1
• 235000010469 Glycine max Nutrition 0.000 description 1
• 229920002907 Guar gum Polymers 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• 206010019280 Heart failures Diseases 0.000 description 1
• 101100499142 Homo sapiens DGAT1 gene Proteins 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 206010022489 Insulin Resistance Diseases 0.000 description 1
• 229940122355 Insulin sensitizer Drugs 0.000 description 1
• 206010022998 Irritability Diseases 0.000 description 1
• VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
• 150000000994 L-ascorbates Chemical class 0.000 description 1
• QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
• 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
• 239000004166 Lanolin Substances 0.000 description 1
• 239000005639 Lauric acid Substances 0.000 description 1
• 239000004367 Lipase Substances 0.000 description 1
• 108090001060 Lipase Proteins 0.000 description 1
• 102000004882 Lipase Human genes 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
• CESYKOGBSMNBPD-UHFFFAOYSA-N Methyclothiazide Chemical compound ClC1=C(S(N)(=O)=O)C=C2S(=O)(=O)N(C)C(CCl)NC2=C1 CESYKOGBSMNBPD-UHFFFAOYSA-N 0.000 description 1
• IBAQFPQHRJAVAV-ULAWRXDQSA-N Miglitol Chemical compound OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO IBAQFPQHRJAVAV-ULAWRXDQSA-N 0.000 description 1
• 229920000881 Modified starch Polymers 0.000 description 1
• PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 1
• 241000238367 Mya arenaria Species 0.000 description 1
• MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
• FIWILGQIZHDAQG-UHFFFAOYSA-N NC1=C(C(=O)NCC2=CC=C(C=C2)OCC(F)(F)F)C=C(C(=N1)N)N1N=C(N=C1)C1(CC1)C(F)(F)F Chemical compound NC1=C(C(=O)NCC2=CC=C(C=C2)OCC(F)(F)F)C=C(C(=N1)N)N1N=C(N=C1)C1(CC1)C(F)(F)F FIWILGQIZHDAQG-UHFFFAOYSA-N 0.000 description 1
• GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
• BVTWSRUFFHBCHO-MNOVXSKESA-N OC([C@@H](CCC1)[C@@H]1C(c(cc1)ccc1Br)=O)=O Chemical compound OC([C@@H](CCC1)[C@@H]1C(c(cc1)ccc1Br)=O)=O BVTWSRUFFHBCHO-MNOVXSKESA-N 0.000 description 1
• 206010033307 Overweight Diseases 0.000 description 1
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
• 102000004316 Oxidoreductases Human genes 0.000 description 1
• 108090000854 Oxidoreductases Proteins 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 102100038831 Peroxisome proliferator-activated receptor alpha Human genes 0.000 description 1
• 102100038824 Peroxisome proliferator-activated receptor delta Human genes 0.000 description 1
• QPFYXYFORQJZEC-FOCLMDBBSA-N Phenazopyridine Chemical compound NC1=NC(N)=CC=C1\N=N\C1=CC=CC=C1 QPFYXYFORQJZEC-FOCLMDBBSA-N 0.000 description 1
• 229920001214 Polysorbate 60 Polymers 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• CYLWJCABXYDINA-UHFFFAOYSA-N Polythiazide Polymers ClC1=C(S(N)(=O)=O)C=C2S(=O)(=O)N(C)C(CSCC(F)(F)F)NC2=C1 CYLWJCABXYDINA-UHFFFAOYSA-N 0.000 description 1
• TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
• GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
• IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
• FTALBRSUTCGOEG-UHFFFAOYSA-N Riluzole Chemical compound C1=C(OC(F)(F)F)C=C2SC(N)=NC2=C1 FTALBRSUTCGOEG-UHFFFAOYSA-N 0.000 description 1
• RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 1
• 229920001800 Shellac Polymers 0.000 description 1
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
• DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
• IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
• 241000256251 Spodoptera frugiperda Species 0.000 description 1
• 229930182558 Sterol Natural products 0.000 description 1
• ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
• LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
• DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
• 229940123464 Thiazolidinedione Drugs 0.000 description 1
• ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
• JLRGJRBPOGGCBT-UHFFFAOYSA-N Tolbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 JLRGJRBPOGGCBT-UHFFFAOYSA-N 0.000 description 1
• 102000004142 Trypsin Human genes 0.000 description 1
• 108090000631 Trypsin Proteins 0.000 description 1
• FZNCGRZWXLXZSZ-CIQUZCHMSA-N Voglibose Chemical compound OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O FZNCGRZWXLXZSZ-CIQUZCHMSA-N 0.000 description 1
• UWAOJIWUVCMBAZ-UHFFFAOYSA-N [1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-dimethylazanium;chloride Chemical compound Cl.C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UWAOJIWUVCMBAZ-UHFFFAOYSA-N 0.000 description 1
• JSIQRJQKMVTGJN-UHFFFAOYSA-N [2-(4-chlorophenyl)-2-oxoethyl] thiocyanate Chemical compound ClC1=CC=C(C(=O)CSC#N)C=C1 JSIQRJQKMVTGJN-UHFFFAOYSA-N 0.000 description 1
• GPWHDDKQSYOYBF-UHFFFAOYSA-N ac1l2u0q Chemical compound Br[Br-]Br GPWHDDKQSYOYBF-UHFFFAOYSA-N 0.000 description 1
• 229960002632 acarbose Drugs 0.000 description 1
• XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
• 150000001242 acetic acid derivatives Chemical class 0.000 description 1
• 239000003377 acid catalyst Substances 0.000 description 1
• 239000003929 acidic solution Substances 0.000 description 1
• 239000002535 acidifier Substances 0.000 description 1
• 229960003526 acipimox Drugs 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 125000002252 acyl group Chemical group 0.000 description 1
• 125000004442 acylamino group Chemical group 0.000 description 1
• WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical class OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 1
• 210000001789 adipocyte Anatomy 0.000 description 1
• 239000003463 adsorbent Substances 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 229940023476 agar Drugs 0.000 description 1
• 239000003513 alkali Substances 0.000 description 1
• 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
• 230000003113 alkalizing effect Effects 0.000 description 1
• 150000001336 alkenes Chemical class 0.000 description 1
• 230000029936 alkylation Effects 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• 125000002947 alkylene group Chemical group 0.000 description 1
• AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• LDPIQRWHBLWKPR-UHFFFAOYSA-N aminoboronic acid Chemical compound NB(O)O LDPIQRWHBLWKPR-UHFFFAOYSA-N 0.000 description 1
• 239000001099 ammonium carbonate Substances 0.000 description 1
• 235000012501 ammonium carbonate Nutrition 0.000 description 1
• VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
• 150000003863 ammonium salts Chemical class 0.000 description 1
• SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 1
• 210000003484 anatomy Anatomy 0.000 description 1
• BLLGDDLTTAIIQY-UHFFFAOYSA-N anilinoboronic acid Chemical compound OB(O)NC1=CC=CC=C1 BLLGDDLTTAIIQY-UHFFFAOYSA-N 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 239000010617 anise oil Substances 0.000 description 1
• 230000000844 anti-bacterial effect Effects 0.000 description 1
• 230000000843 anti-fungal effect Effects 0.000 description 1
• 229940125708 antidiabetic agent Drugs 0.000 description 1
• 239000003472 antidiabetic agent Substances 0.000 description 1
• 229940121375 antifungal agent Drugs 0.000 description 1
• 229940127088 antihypertensive drug Drugs 0.000 description 1
• 230000003078 antioxidant effect Effects 0.000 description 1
• 235000019789 appetite Nutrition 0.000 description 1
• 230000036528 appetite Effects 0.000 description 1
• 239000012300 argon atmosphere Substances 0.000 description 1
• 238000000149 argon plasma sintering Methods 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
• IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
• 239000000605 aspartame Substances 0.000 description 1
• 235000010357 aspartame Nutrition 0.000 description 1
• 229960003438 aspartame Drugs 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-L aspartate group Chemical class N[C@@H](CC(=O)[O-])C(=O)[O-] CKLJMWTZIZZHCS-REOHCLBHSA-L 0.000 description 1
• 125000004429 atom Chemical group 0.000 description 1
• 229960005370 atorvastatin Drugs 0.000 description 1
• MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical class O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 description 1
• 230000003385 bacteriostatic effect Effects 0.000 description 1
• 229960003515 bendroflumethiazide Drugs 0.000 description 1
• HDWIHXWEUNVBIY-UHFFFAOYSA-N bendroflumethiazidum Chemical compound C1=C(C(F)(F)F)C(S(=O)(=O)N)=CC(S(N2)(=O)=O)=C1NC2CC1=CC=CC=C1 HDWIHXWEUNVBIY-UHFFFAOYSA-N 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
• 229960001950 benzethonium chloride Drugs 0.000 description 1
• UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
• 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
• PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
• NDTSRXAMMQDVSW-UHFFFAOYSA-N benzthiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(S(N2)(=O)=O)=C1N=C2CSCC1=CC=CC=C1 NDTSRXAMMQDVSW-UHFFFAOYSA-N 0.000 description 1
• 229960001541 benzthiazide Drugs 0.000 description 1
• 235000019445 benzyl alcohol Nutrition 0.000 description 1
• 229960004217 benzyl alcohol Drugs 0.000 description 1
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
• XMIIGOLPHOKFCH-UHFFFAOYSA-N beta-phenylpropanoic acid Natural products OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
• 150000004283 biguanides Chemical class 0.000 description 1
• 229920000080 bile acid sequestrant Polymers 0.000 description 1
• 229940096699 bile acid sequestrants Drugs 0.000 description 1
• 210000000013 bile duct Anatomy 0.000 description 1
• 235000010290 biphenyl Nutrition 0.000 description 1
• 239000004305 biphenyl Substances 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-M bisulphate group Chemical group S([O-])(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
• 230000008499 blood brain barrier function Effects 0.000 description 1
• 210000001218 blood-brain barrier Anatomy 0.000 description 1
• 229910021538 borax Inorganic materials 0.000 description 1
• ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
• 125000005620 boronic acid group Chemical class 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 244000309464 bull Species 0.000 description 1
• MAEIEVLCKWDQJH-UHFFFAOYSA-N bumetanide Chemical compound CCCCNC1=CC(C(O)=O)=CC(S(N)(=O)=O)=C1OC1=CC=CC=C1 MAEIEVLCKWDQJH-UHFFFAOYSA-N 0.000 description 1
• 229960004064 bumetanide Drugs 0.000 description 1
• 150000004648 butanoic acid derivatives Chemical class 0.000 description 1
• KMGBZBJJOKUPIA-UHFFFAOYSA-N butyl iodide Chemical compound CCCCI KMGBZBJJOKUPIA-UHFFFAOYSA-N 0.000 description 1
• 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
• CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
• 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
• 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
• 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
• 229940067596 butylparaben Drugs 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical class C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
• 229960000830 captopril Drugs 0.000 description 1
• FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 229910002092 carbon dioxide Inorganic materials 0.000 description 1
• 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
• 125000005518 carboxamido group Chemical group 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 229940105329 carboxymethylcellulose Drugs 0.000 description 1
• 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 238000000423 cell based assay Methods 0.000 description 1
• 210000003169 central nervous system Anatomy 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 210000004289 cerebral ventricle Anatomy 0.000 description 1
• 229960005110 cerivastatin Drugs 0.000 description 1
• SEERZIQQUAZTOL-ANMDKAQQSA-N cerivastatin Chemical compound COCC1=C(C(C)C)N=C(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C1C1=CC=C(F)C=C1 SEERZIQQUAZTOL-ANMDKAQQSA-N 0.000 description 1
• GPUADMRJQVPIAS-QCVDVZFFSA-M cerivastatin sodium Chemical compound [Na+].COCC1=C(C(C)C)N=C(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 GPUADMRJQVPIAS-QCVDVZFFSA-M 0.000 description 1
• 210000003679 cervix uteri Anatomy 0.000 description 1
• 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
• YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 1
• 235000020426 cherry syrup Nutrition 0.000 description 1
• KYKAJFCTULSVSH-UHFFFAOYSA-N chloro(fluoro)methane Chemical compound F[C]Cl KYKAJFCTULSVSH-UHFFFAOYSA-N 0.000 description 1
• 229960004926 chlorobutanol Drugs 0.000 description 1
• 229960002155 chlorothiazide Drugs 0.000 description 1
• 229960001523 chlortalidone Drugs 0.000 description 1
• JIVPVXMEBJLZRO-UHFFFAOYSA-N chlorthalidone Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C2(O)C3=CC=CC=C3C(=O)N2)=C1 JIVPVXMEBJLZRO-UHFFFAOYSA-N 0.000 description 1
• 238000013375 chromatographic separation Methods 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• WBYWAXJHAXSJNI-UHFFFAOYSA-N cinnamic acid Chemical class OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
• 239000010630 cinnamon oil Substances 0.000 description 1
• 229960004106 citric acid Drugs 0.000 description 1
• 239000008395 clarifying agent Substances 0.000 description 1
• 229960001214 clofibrate Drugs 0.000 description 1
• KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 239000003240 coconut oil Substances 0.000 description 1
• 235000019864 coconut oil Nutrition 0.000 description 1
• 239000008119 colloidal silica Substances 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 239000012230 colorless oil Substances 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 229940125904 compound 1 Drugs 0.000 description 1
• 229940125773 compound 10 Drugs 0.000 description 1
• 229940125782 compound 2 Drugs 0.000 description 1
• 229940126214 compound 3 Drugs 0.000 description 1
• 229940125898 compound 5 Drugs 0.000 description 1
• 238000013329 compounding Methods 0.000 description 1
• 238000009833 condensation Methods 0.000 description 1
• 230000005494 condensation Effects 0.000 description 1
• 229920001577 copolymer Polymers 0.000 description 1
• 229910052802 copper Inorganic materials 0.000 description 1
• 239000010949 copper Substances 0.000 description 1
• 229940099112 cornstarch Drugs 0.000 description 1
• 238000011262 co‐therapy Methods 0.000 description 1
• 238000002425 crystallisation Methods 0.000 description 1
• 230000008025 crystallization Effects 0.000 description 1
• ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
• TXWOGHSRPAYOML-UHFFFAOYSA-M cyclobutanecarboxylate Chemical compound [O-]C(=O)C1CCC1 TXWOGHSRPAYOML-UHFFFAOYSA-M 0.000 description 1
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• HKIACFLJVISALE-UHFFFAOYSA-N cyclopentanecarboxylic acid hexanoic acid Chemical compound C(CCCCC)(=O)O.C1(CCCC1)C(=O)O HKIACFLJVISALE-UHFFFAOYSA-N 0.000 description 1
• 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
• YMGUBTXCNDTFJI-UHFFFAOYSA-M cyclopropanecarboxylate Chemical compound [O-]C(=O)C1CC1 YMGUBTXCNDTFJI-UHFFFAOYSA-M 0.000 description 1
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
• 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
• 229940075482 d & c green 5 Drugs 0.000 description 1
• 229940090962 d&c orange no. 5 Drugs 0.000 description 1
• DEZRYPDIMOWBDS-UHFFFAOYSA-N dcm dichloromethane Chemical compound ClCCl.ClCCl DEZRYPDIMOWBDS-UHFFFAOYSA-N 0.000 description 1
• 238000006114 decarboxylation reaction Methods 0.000 description 1
• 229960005227 delapril Drugs 0.000 description 1
• WOUOLAUOZXOLJQ-MBSDFSHPSA-N delapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N(CC(O)=O)C1CC2=CC=CC=C2C1)CC1=CC=CC=C1 WOUOLAUOZXOLJQ-MBSDFSHPSA-N 0.000 description 1
• 229940124447 delivery agent Drugs 0.000 description 1
• 230000008021 deposition Effects 0.000 description 1
• 238000010511 deprotection reaction Methods 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 230000018109 developmental process Effects 0.000 description 1
• 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 1
• 150000008050 dialkyl sulfates Chemical class 0.000 description 1
• LMEDOLJKVASKTP-UHFFFAOYSA-N dibutyl sulfate Chemical compound CCCCOS(=O)(=O)OCCCC LMEDOLJKVASKTP-UHFFFAOYSA-N 0.000 description 1
• 150000001991 dicarboxylic acids Chemical class 0.000 description 1
• 150000005690 diesters Chemical class 0.000 description 1
• 230000000378 dietary effect Effects 0.000 description 1
• ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
• NBUBXXFBXDUOHG-UHFFFAOYSA-N diethyl 2-(2-methoxyethyl)propanedioate Chemical compound CCOC(=O)C(CCOC)C(=O)OCC NBUBXXFBXDUOHG-UHFFFAOYSA-N 0.000 description 1
• ZXZODXXCOXJTEX-UHFFFAOYSA-N diethyl 2-[2-(4-bromophenyl)-2-oxoethyl]-2-propylpropanedioate Chemical compound CCOC(=O)C(C(=O)OCC)(CCC)CC(=O)C1=CC=C(Br)C=C1 ZXZODXXCOXJTEX-UHFFFAOYSA-N 0.000 description 1
• GRRSDGHTSMJICM-UHFFFAOYSA-N diethyl 2-propylpropanedioate Chemical compound CCOC(=O)C(CCC)C(=O)OCC GRRSDGHTSMJICM-UHFFFAOYSA-N 0.000 description 1
• XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
• 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
• 125000006001 difluoroethyl group Chemical group 0.000 description 1
• 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 229940043279 diisopropylamine Drugs 0.000 description 1
• HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 1
• 229960004166 diltiazem Drugs 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
• VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
• UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
• GAFRWLVTHPVQGK-UHFFFAOYSA-N dipentyl sulfate Chemical class CCCCCOS(=O)(=O)OCCCCC GAFRWLVTHPVQGK-UHFFFAOYSA-N 0.000 description 1
• 238000007907 direct compression Methods 0.000 description 1
• 239000007884 disintegrant Substances 0.000 description 1
• FUZBPOHHSBDTJQ-CFOQQKEYSA-L disodium;5-[(2r)-2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate Chemical compound [Na+].[Na+].C1([C@@H](O)CN[C@@H](CC=2C=C3OC(OC3=CC=2)(C([O-])=O)C([O-])=O)C)=CC=CC(Cl)=C1 FUZBPOHHSBDTJQ-CFOQQKEYSA-L 0.000 description 1
• FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
• 239000006185 dispersion Substances 0.000 description 1
• CETRZFQIITUQQL-UHFFFAOYSA-N dmso dimethylsulfoxide Chemical compound CS(C)=O.CS(C)=O CETRZFQIITUQQL-UHFFFAOYSA-N 0.000 description 1
• MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
• 229940043264 dodecyl sulfate Drugs 0.000 description 1
• 239000000890 drug combination Substances 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 229940124274 edetate disodium Drugs 0.000 description 1
• 229960001484 edetic acid Drugs 0.000 description 1
• 238000002451 electron ionisation mass spectrometry Methods 0.000 description 1
• 229960000873 enalapril Drugs 0.000 description 1
• GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 description 1
• 239000008393 encapsulating agent Substances 0.000 description 1
• 210000004696 endometrium Anatomy 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 229950002375 englitazone Drugs 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
• 229940011411 erythrosine Drugs 0.000 description 1
• 235000012732 erythrosine Nutrition 0.000 description 1
• 239000004174 erythrosine Substances 0.000 description 1
• 238000010931 ester hydrolysis Methods 0.000 description 1
• CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
• OCLXJTCGWSSVOE-UHFFFAOYSA-N ethanol etoh Chemical compound CCO.CCO OCLXJTCGWSSVOE-UHFFFAOYSA-N 0.000 description 1
• DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
• ZOOODBUHSVUZEM-UHFFFAOYSA-N ethoxymethanedithioic acid Chemical compound CCOC(S)=S ZOOODBUHSVUZEM-UHFFFAOYSA-N 0.000 description 1
• VFRSADQPWYCXDG-LEUCUCNGSA-N ethyl (2s,5s)-5-methylpyrrolidine-2-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCOC(=O)[C@@H]1CC[C@H](C)N1 VFRSADQPWYCXDG-LEUCUCNGSA-N 0.000 description 1
• IHVKWSCHWDRMNB-UHFFFAOYSA-N ethyl 4-[4-(4-aminophenyl)-2-methylphenyl]-4-oxo-2-(2-phenylethyl)butanoate Chemical compound C=1C=C(C=2C=CC(N)=CC=2)C=C(C)C=1C(=O)CC(C(=O)OCC)CCC1=CC=CC=C1 IHVKWSCHWDRMNB-UHFFFAOYSA-N 0.000 description 1
• 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
• LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
• 229940093471 ethyl oleate Drugs 0.000 description 1
• 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
• 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
• NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
• OJCSPXHYDFONPU-UHFFFAOYSA-N etoac etoac Chemical compound CCOC(C)=O.CCOC(C)=O OJCSPXHYDFONPU-UHFFFAOYSA-N 0.000 description 1
• 229960003501 etofibrate Drugs 0.000 description 1
• XXRVYAFBUDSLJX-UHFFFAOYSA-N etofibrate Chemical compound C=1C=CN=CC=1C(=O)OCCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 XXRVYAFBUDSLJX-UHFFFAOYSA-N 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 238000000105 evaporative light scattering detection Methods 0.000 description 1
• 238000010228 ex vivo assay Methods 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• OLNTVTPDXPETLC-XPWALMASSA-N ezetimibe Chemical compound N1([C@@H]([C@H](C1=O)CC[C@H](O)C=1C=CC(F)=CC=1)C=1C=CC(O)=CC=1)C1=CC=C(F)C=C1 OLNTVTPDXPETLC-XPWALMASSA-N 0.000 description 1
• 150000002191 fatty alcohols Chemical class 0.000 description 1
• 229940051147 fd&c yellow no. 6 Drugs 0.000 description 1
• 229960002297 fenofibrate Drugs 0.000 description 1
• YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 description 1
• JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
• 229960005191 ferric oxide Drugs 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 235000019634 flavors Nutrition 0.000 description 1
• 238000007667 floating Methods 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• RGUQWGXAYZNLMI-UHFFFAOYSA-N flumethiazide Chemical compound C1=C(C(F)(F)F)C(S(=O)(=O)N)=CC2=C1NC=NS2(=O)=O RGUQWGXAYZNLMI-UHFFFAOYSA-N 0.000 description 1
• 229910052731 fluorine Inorganic materials 0.000 description 1
• 229960003765 fluvastatin Drugs 0.000 description 1
• 239000001530 fumaric acid Substances 0.000 description 1
• 229960002598 fumaric acid Drugs 0.000 description 1
• ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
• 229960003883 furosemide Drugs 0.000 description 1
• 210000000232 gallbladder Anatomy 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 229960003627 gemfibrozil Drugs 0.000 description 1
• 230000008570 general process Effects 0.000 description 1
• 239000012362 glacial acetic acid Substances 0.000 description 1
• 229960004580 glibenclamide Drugs 0.000 description 1
• ZJJXGWJIGJFDTL-UHFFFAOYSA-N glipizide Chemical compound C1=NC(C)=CN=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZJJXGWJIGJFDTL-UHFFFAOYSA-N 0.000 description 1
• 229960001381 glipizide Drugs 0.000 description 1
• MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
• 229960004666 glucagon Drugs 0.000 description 1
• 239000000174 gluconic acid Substances 0.000 description 1
• 235000012208 gluconic acid Nutrition 0.000 description 1
• 229940095884 glucophage Drugs 0.000 description 1
• 230000010030 glucose lowering effect Effects 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 125000005456 glyceride group Chemical group 0.000 description 1
• YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
• SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
• 150000002314 glycerols Chemical class 0.000 description 1
• 229960004275 glycolic acid Drugs 0.000 description 1
• 150000002334 glycols Chemical class 0.000 description 1
• 229930182470 glycoside Natural products 0.000 description 1
• 239000000665 guar gum Substances 0.000 description 1
• 235000010417 guar gum Nutrition 0.000 description 1
• 229960002154 guar gum Drugs 0.000 description 1
• 229920000591 gum Polymers 0.000 description 1
• 229940093915 gynecological organic acid Drugs 0.000 description 1
• 150000004820 halides Chemical class 0.000 description 1
• 230000020169 heat generation Effects 0.000 description 1
• DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
• MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
• 125000000623 heterocyclic group Chemical class 0.000 description 1
• FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
• 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 238000004896 high resolution mass spectrometry Methods 0.000 description 1
• 239000003906 humectant Substances 0.000 description 1
• 229960000443 hydrochloric acid Drugs 0.000 description 1
• 229960002003 hydrochlorothiazide Drugs 0.000 description 1
• XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
• ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
• 239000008311 hydrophilic ointment Substances 0.000 description 1
• 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
• 239000012729 immediate-release (IR) formulation Substances 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 239000012535 impurity Substances 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 238000005462 in vivo assay Methods 0.000 description 1
• KHLVKKOJDHCJMG-QDBORUFSSA-L indigo carmine Chemical compound [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 description 1
• 239000004179 indigotine Substances 0.000 description 1
• 235000012738 indigotine Nutrition 0.000 description 1
• 239000012442 inert solvent Substances 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 229910017053 inorganic salt Inorganic materials 0.000 description 1
• QWXYZCJEXYQNEI-OSZHWHEXSA-N intermediate I Chemical compound COC(=O)[C@@]1(C=O)[C@H]2CC=[N+](C\C2=C\C)CCc2c1[nH]c1ccccc21 QWXYZCJEXYQNEI-OSZHWHEXSA-N 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• 238000005040 ion trap Methods 0.000 description 1
• 229960002198 irbesartan Drugs 0.000 description 1
• YCPOHTHPUREGFM-UHFFFAOYSA-N irbesartan Chemical compound O=C1N(CC=2C=CC(=CC=2)C=2C(=CC=CC=2)C=2[N]N=NN=2)C(CCCC)=NC21CCCC2 YCPOHTHPUREGFM-UHFFFAOYSA-N 0.000 description 1
• SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
• 125000001261 isocyanato group Chemical group *N=C=O 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 239000000644 isotonic solution Substances 0.000 description 1
• LVHBHZANLOWSRM-UHFFFAOYSA-N itaconic acid Chemical compound OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
• ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
• 229960000829 kaolin Drugs 0.000 description 1
• 150000002576 ketones Chemical class 0.000 description 1
• 235000014655 lactic acid Nutrition 0.000 description 1
• 239000004310 lactic acid Substances 0.000 description 1
• 229960000448 lactic acid Drugs 0.000 description 1
• 229960001375 lactose Drugs 0.000 description 1
• 235000019388 lanolin Nutrition 0.000 description 1
• 229940039717 lanolin Drugs 0.000 description 1
• 230000007775 late Effects 0.000 description 1
• 235000019421 lipase Nutrition 0.000 description 1
• 230000004130 lipolysis Effects 0.000 description 1
• 239000008297 liquid dosage form Substances 0.000 description 1
• 229960004773 losartan Drugs 0.000 description 1
• KJJZZJSZUJXYEA-UHFFFAOYSA-N losartan Chemical compound CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C=2[N]N=NN=2)C=C1 KJJZZJSZUJXYEA-UHFFFAOYSA-N 0.000 description 1
• 229960004844 lovastatin Drugs 0.000 description 1
• PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 1
• QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 1
• 235000004213 low-fat Nutrition 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 159000000003 magnesium salts Chemical class 0.000 description 1
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
• IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
• 229960002510 mandelic acid Drugs 0.000 description 1
• 229960001855 mannitol Drugs 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 238000002483 medication Methods 0.000 description 1
• 229950004994 meglitinide Drugs 0.000 description 1
• 239000000155 melt Substances 0.000 description 1
• 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
• 229940041616 menthol Drugs 0.000 description 1
• COTNUBDHGSIOTA-UHFFFAOYSA-N meoh methanol Chemical compound OC.OC COTNUBDHGSIOTA-UHFFFAOYSA-N 0.000 description 1
• 229940045623 meridia Drugs 0.000 description 1
• 208000030159 metabolic disease Diseases 0.000 description 1
• FMDZVWXTHAMLRZ-HZPDHXFCSA-N methyl (1r,2r)-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]cyclopentane-1-carboxylate Chemical compound COC(=O)[C@@H]1CCC[C@H]1C(=O)C1=CC=C(B2OC(C)(C)C(C)(C)O2)C=C1 FMDZVWXTHAMLRZ-HZPDHXFCSA-N 0.000 description 1
• GXTZPHBSUFBNIP-WOJBJXKFSA-N methyl (1r,2r)-2-[4-[4-(1h-benzimidazol-2-ylamino)-3-fluorophenyl]benzoyl]cyclopentane-1-carboxylate Chemical compound COC(=O)[C@@H]1CCC[C@H]1C(=O)C1=CC=C(C=2C=C(F)C(NC=3NC4=CC=CC=C4N=3)=CC=2)C=C1 GXTZPHBSUFBNIP-WOJBJXKFSA-N 0.000 description 1
• XKJACWYQAFNKQK-NWDGAFQWSA-N methyl (1r,2s)-2-(4-bromobenzoyl)cyclopentane-1-carboxylate Chemical compound COC(=O)[C@@H]1CCC[C@@H]1C(=O)C1=CC=C(Br)C=C1 XKJACWYQAFNKQK-NWDGAFQWSA-N 0.000 description 1
• XGTFDXYFGVZYBC-UHFFFAOYSA-N methyl 1-(2-chloro-2-oxoethyl)cyclopentane-1-carboxylate Chemical compound COC(=O)C1(CC(Cl)=O)CCCC1 XGTFDXYFGVZYBC-UHFFFAOYSA-N 0.000 description 1
• VVSMJPCJRLJHFF-UHFFFAOYSA-N methyl 2-[4-(3-fluoro-4-formamidophenyl)benzoyl]cyclopentane-1-carboxylate Chemical compound COC(=O)C1CCCC1C(=O)C1=CC=C(C=2C=C(F)C(NC=O)=CC=2)C=C1 VVSMJPCJRLJHFF-UHFFFAOYSA-N 0.000 description 1
• OZCFHHBJOFHTGR-UHFFFAOYSA-N methyl 2-[4-(4-amino-3-fluorophenyl)benzoyl]cyclopentane-1-carboxylate Chemical compound COC(=O)C1CCCC1C(=O)C1=CC=C(C=2C=C(F)C(N)=CC=2)C=C1 OZCFHHBJOFHTGR-UHFFFAOYSA-N 0.000 description 1
• XOERXLWVJMDHDW-UHFFFAOYSA-N methyl 2-[4-(4-aminophenyl)benzoyl]cyclopentane-1-carboxylate Chemical compound COC(=O)C1CCCC1C(=O)C1=CC=C(C=2C=CC(N)=CC=2)C=C1 XOERXLWVJMDHDW-UHFFFAOYSA-N 0.000 description 1
• LCGIMSXOGWABDK-UHFFFAOYSA-N methyl 4-[2-[4-(4-nitrophenyl)phenyl]-2-oxoethyl]oxane-4-carboxylate Chemical compound C=1C=C(C=2C=CC(=CC=2)[N+]([O-])=O)C=CC=1C(=O)CC1(C(=O)OC)CCOCC1 LCGIMSXOGWABDK-UHFFFAOYSA-N 0.000 description 1
• IKFPJNWOOIFPIJ-UHFFFAOYSA-N methyl 4-[4-(3-fluoro-4-formamidophenyl)phenyl]-2,2-dimethyl-4-oxobutanoate Chemical compound C1=CC(C(=O)CC(C)(C)C(=O)OC)=CC=C1C1=CC=C(NC=O)C(F)=C1 IKFPJNWOOIFPIJ-UHFFFAOYSA-N 0.000 description 1
• DZIUQCBKIIPGAL-UHFFFAOYSA-N methyl 4-[4-(3-methoxy-4-nitrophenyl)phenyl]-2,2-dimethyl-4-oxobutanoate Chemical compound C1=CC(C(=O)CC(C)(C)C(=O)OC)=CC=C1C1=CC=C([N+]([O-])=O)C(OC)=C1 DZIUQCBKIIPGAL-UHFFFAOYSA-N 0.000 description 1
• BBBVRPCKQVBOQO-UHFFFAOYSA-N methyl 4-[4-(4-aminophenyl)phenyl]-2-[2-(dimethylamino)ethyl]-4-oxobutanoate Chemical compound C1=CC(C(=O)CC(CCN(C)C)C(=O)OC)=CC=C1C1=CC=C(N)C=C1 BBBVRPCKQVBOQO-UHFFFAOYSA-N 0.000 description 1
• FJJSNBOIUOXLRZ-UHFFFAOYSA-N methyl 4-[4-(4-aminophenyl)phenyl]-4-oxo-2-(2-phenylethyl)butanoate Chemical compound C=1C=C(C=2C=CC(N)=CC=2)C=CC=1C(=O)CC(C(=O)OC)CCC1=CC=CC=C1 FJJSNBOIUOXLRZ-UHFFFAOYSA-N 0.000 description 1
• JDIKHBOBHXCUSA-UHFFFAOYSA-N methyl 4-[4-(4-formamido-3-methylphenyl)phenyl]-2,2-dimethyl-4-oxobutanoate Chemical compound C1=CC(C(=O)CC(C)(C)C(=O)OC)=CC=C1C1=CC=C(NC=O)C(C)=C1 JDIKHBOBHXCUSA-UHFFFAOYSA-N 0.000 description 1
• DOGCGBPVRDBOPH-UHFFFAOYSA-N methyl 4-[4-[4-(1,3-benzothiazol-2-ylamino)phenyl]phenyl]-2,2-dimethyl-4-oxobutanoate Chemical compound C1=CC(C(=O)CC(C)(C)C(=O)OC)=CC=C1C(C=C1)=CC=C1NC1=NC2=CC=CC=C2S1 DOGCGBPVRDBOPH-UHFFFAOYSA-N 0.000 description 1
• 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
• 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
• 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
• 229960002216 methylparaben Drugs 0.000 description 1
• 239000004200 microcrystalline wax Substances 0.000 description 1
• 235000019808 microcrystalline wax Nutrition 0.000 description 1
• 229960001110 miglitol Drugs 0.000 description 1
• 150000007522 mineralic acids Chemical class 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 229940111688 monobasic potassium phosphate Drugs 0.000 description 1
• 235000019796 monopotassium phosphate Nutrition 0.000 description 1
• PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
• YDXTZECPCWGSQR-UHFFFAOYSA-N n-(2-chloro-1,3-benzothiazol-5-yl)acetamide Chemical compound CC(=O)NC1=CC=C2SC(Cl)=NC2=C1 YDXTZECPCWGSQR-UHFFFAOYSA-N 0.000 description 1
• YNNAXDWMVUVGQX-UHFFFAOYSA-N n-(2-chloro-1,3-benzothiazol-6-yl)acetamide Chemical compound CC(=O)NC1=CC=C2N=C(Cl)SC2=C1 YNNAXDWMVUVGQX-UHFFFAOYSA-N 0.000 description 1
• UKUGIWVMVFUOSU-UHFFFAOYSA-N n-(4-bromo-2-fluorophenyl)-1,3-benzothiazol-2-amine Chemical compound FC1=CC(Br)=CC=C1NC1=NC2=CC=CC=C2S1 UKUGIWVMVFUOSU-UHFFFAOYSA-N 0.000 description 1
• NGGFFMRXWGTCJF-UHFFFAOYSA-N n-(4-bromo-2-fluorophenyl)-5,7-dimethyl-1,3-benzothiazol-2-amine Chemical compound N=1C2=CC(C)=CC(C)=C2SC=1NC1=CC=C(Br)C=C1F NGGFFMRXWGTCJF-UHFFFAOYSA-N 0.000 description 1
• KENOBVFUXNPWFL-UHFFFAOYSA-N n-(4-bromo-2-fluorophenyl)-5-(trifluoromethyl)-1,3-benzothiazol-2-amine Chemical compound FC1=CC(Br)=CC=C1NC1=NC2=CC(C(F)(F)F)=CC=C2S1 KENOBVFUXNPWFL-UHFFFAOYSA-N 0.000 description 1
• LFERYJFVTQEXOU-UHFFFAOYSA-N n-(4-bromo-2-fluorophenyl)-6-(trifluoromethyl)-1,3-benzothiazol-2-amine Chemical compound FC1=CC(Br)=CC=C1NC1=NC2=CC=C(C(F)(F)F)C=C2S1 LFERYJFVTQEXOU-UHFFFAOYSA-N 0.000 description 1
• RAGBEYLDOVOUCD-UHFFFAOYSA-N n-(4-bromo-2-fluorophenyl)-6-methoxy-1,3-benzothiazol-2-amine Chemical compound S1C2=CC(OC)=CC=C2N=C1NC1=CC=C(Br)C=C1F RAGBEYLDOVOUCD-UHFFFAOYSA-N 0.000 description 1
• BPLOEDHCZSVHMS-UHFFFAOYSA-N n-(4-bromo-2-fluorophenyl)-6-propan-2-yl-1,3-benzothiazol-2-amine Chemical compound S1C2=CC(C(C)C)=CC=C2N=C1NC1=CC=C(Br)C=C1F BPLOEDHCZSVHMS-UHFFFAOYSA-N 0.000 description 1
• VNHLHHAXIJZPQO-UHFFFAOYSA-N n-(4-bromophenyl)-1,3-benzothiazol-2-amine Chemical compound C1=CC(Br)=CC=C1NC1=NC2=CC=CC=C2S1 VNHLHHAXIJZPQO-UHFFFAOYSA-N 0.000 description 1
• LJQQJHXRDHASBK-UHFFFAOYSA-N n-(4-bromophenyl)-5-(trifluoromethyl)-1,3-benzothiazol-2-amine Chemical compound N=1C2=CC(C(F)(F)F)=CC=C2SC=1NC1=CC=C(Br)C=C1 LJQQJHXRDHASBK-UHFFFAOYSA-N 0.000 description 1
• PMPFTLUENQWOAW-UHFFFAOYSA-N n-(4-bromophenyl)-6-propan-2-yl-1,3-benzothiazol-2-amine Chemical compound S1C2=CC(C(C)C)=CC=C2N=C1NC1=CC=C(Br)C=C1 PMPFTLUENQWOAW-UHFFFAOYSA-N 0.000 description 1
• AFGGWSJMSKPJPI-UHFFFAOYSA-N n-(4-iodo-2-methylphenyl)formamide Chemical compound CC1=CC(I)=CC=C1NC=O AFGGWSJMSKPJPI-UHFFFAOYSA-N 0.000 description 1
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• KVBGVZZKJNLNJU-UHFFFAOYSA-M naphthalene-2-sulfonate Chemical compound C1=CC=CC2=CC(S(=O)(=O)[O-])=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-M 0.000 description 1
• OELFLUMRDSZNSF-BRWVUGGUSA-N nateglinide Chemical compound C1C[C@@H](C(C)C)CC[C@@H]1C(=O)N[C@@H](C(O)=O)CC1=CC=CC=C1 OELFLUMRDSZNSF-BRWVUGGUSA-N 0.000 description 1
• 229960000698 nateglinide Drugs 0.000 description 1
• 229920003052 natural elastomer Polymers 0.000 description 1
• 229920001194 natural rubber Polymers 0.000 description 1
• 239000006199 nebulizer Substances 0.000 description 1
• PKWDZWYVIHVNKS-UHFFFAOYSA-N netoglitazone Chemical compound FC1=CC=CC=C1COC1=CC=C(C=C(CC2C(NC(=O)S2)=O)C=C2)C2=C1 PKWDZWYVIHVNKS-UHFFFAOYSA-N 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
• 229960001597 nifedipine Drugs 0.000 description 1
• 229910017604 nitric acid Inorganic materials 0.000 description 1
• 229940074355 nitric acid Drugs 0.000 description 1
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
• 231100000344 non-irritating Toxicity 0.000 description 1
• 239000002736 nonionic surfactant Substances 0.000 description 1
• 229940073555 nonoxynol-10 Drugs 0.000 description 1
• 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
• GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 1
• 229940098514 octoxynol-9 Drugs 0.000 description 1
• 229920002114 octoxynol-9 Polymers 0.000 description 1
• 239000003883 ointment base Substances 0.000 description 1
• JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
• 235000021313 oleic acid Nutrition 0.000 description 1
• LVRLSYPNFFBYCZ-VGWMRTNUSA-N omapatrilat Chemical compound C([C@H](S)C(=O)N[C@H]1CCS[C@H]2CCC[C@H](N2C1=O)C(=O)O)C1=CC=CC=C1 LVRLSYPNFFBYCZ-VGWMRTNUSA-N 0.000 description 1
• 229950000973 omapatrilat Drugs 0.000 description 1
• 238000000238 one-dimensional nuclear magnetic resonance spectroscopy Methods 0.000 description 1
• 239000003605 opacifier Substances 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 239000006186 oral dosage form Substances 0.000 description 1
• 239000007935 oral tablet Substances 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 150000007530 organic bases Chemical class 0.000 description 1
• 229960001243 orlistat Drugs 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 230000020477 pH reduction Effects 0.000 description 1
• NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 1
• LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 1
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
• 235000010987 pectin Nutrition 0.000 description 1
• 239000001814 pectin Substances 0.000 description 1
• 229920001277 pectin Polymers 0.000 description 1
• 229950008492 pentopril Drugs 0.000 description 1
• 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
• 235000019477 peppermint oil Nutrition 0.000 description 1
• 108091008725 peroxisome proliferator-activated receptors alpha Proteins 0.000 description 1
• 108091008765 peroxisome proliferator-activated receptors β/δ Proteins 0.000 description 1
• 150000004965 peroxy acids Chemical class 0.000 description 1
• JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
• 239000003208 petroleum Substances 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• 229940127557 pharmaceutical product Drugs 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical compound BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 description 1
• ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 description 1
• 229960003243 phenformin Drugs 0.000 description 1
• 229960003742 phenol Drugs 0.000 description 1
• WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
• 229940067107 phenylethyl alcohol Drugs 0.000 description 1
• PDTFCHSETJBPTR-UHFFFAOYSA-N phenylmercuric nitrate Chemical compound [O-][N+](=O)O[Hg]C1=CC=CC=C1 PDTFCHSETJBPTR-UHFFFAOYSA-N 0.000 description 1
• 125000001095 phosphatidyl group Chemical group 0.000 description 1
• ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical compound O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 description 1
• 229940075930 picrate Drugs 0.000 description 1
• OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
• 229960002797 pitavastatin Drugs 0.000 description 1
• VGYFMXBACGZSIL-MCBHFWOFSA-N pitavastatin Chemical compound OC(=O)C[C@H](O)C[C@H](O)\C=C\C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1 VGYFMXBACGZSIL-MCBHFWOFSA-N 0.000 description 1
• 229950010765 pivalate Drugs 0.000 description 1
• IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
• 239000004014 plasticizer Substances 0.000 description 1
• 229920000058 polyacrylate Polymers 0.000 description 1
• 229920001296 polysiloxane Polymers 0.000 description 1
• 229940068968 polysorbate 80 Drugs 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 229960005483 polythiazide Drugs 0.000 description 1
• 229920000046 polythiazide Polymers 0.000 description 1
• 229920002635 polyurethane Polymers 0.000 description 1
• 239000004814 polyurethane Substances 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 230000000291 postprandial effect Effects 0.000 description 1
• 229960003975 potassium Drugs 0.000 description 1
• 235000007686 potassium Nutrition 0.000 description 1
• GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
• JCBJVAJGLKENNC-UHFFFAOYSA-M potassium ethyl xanthate Chemical compound [K+].CCOC([S-])=S JCBJVAJGLKENNC-UHFFFAOYSA-M 0.000 description 1
• OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
• 229940099402 potassium metaphosphate Drugs 0.000 description 1
• WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 1
• 229920001592 potato starch Polymers 0.000 description 1
• 229940116317 potato starch Drugs 0.000 description 1
• 229960002965 pravastatin Drugs 0.000 description 1
• TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 description 1
• 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 108090000765 processed proteins & peptides Proteins 0.000 description 1
• BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
• 239000003380 propellant Substances 0.000 description 1
• 239000000473 propyl gallate Substances 0.000 description 1
• 235000010388 propyl gallate Nutrition 0.000 description 1
• 229940075579 propyl gallate Drugs 0.000 description 1
• 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
• 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
• 229960003415 propylparaben Drugs 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 239000008213 purified water Substances 0.000 description 1
• 229940070891 pyridium Drugs 0.000 description 1
• 229960001455 quinapril Drugs 0.000 description 1
• JSDRRTOADPPCHY-HSQYWUDLSA-N quinapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CC2=CC=CC=C2C1)C(O)=O)CC1=CC=CC=C1 JSDRRTOADPPCHY-HSQYWUDLSA-N 0.000 description 1
• 239000000700 radioactive tracer Substances 0.000 description 1
• 229960003401 ramipril Drugs 0.000 description 1
• HDACQVRGBOVJII-JBDAPHQKSA-N ramipril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCC[C@@H]21)C(O)=O)CC1=CC=CC=C1 HDACQVRGBOVJII-JBDAPHQKSA-N 0.000 description 1
• 102000005962 receptors Human genes 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• 238000007670 refining Methods 0.000 description 1
• 230000008929 regeneration Effects 0.000 description 1
• 238000011069 regeneration method Methods 0.000 description 1
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
• 238000007634 remodeling Methods 0.000 description 1
• 229960002354 repaglinide Drugs 0.000 description 1
• 239000008132 rose water Substances 0.000 description 1
• LALFOYNTGMUKGG-BGRFNVSISA-L rosuvastatin calcium Chemical compound [Ca+2].CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O.CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O LALFOYNTGMUKGG-BGRFNVSISA-L 0.000 description 1
• CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
• 229940081974 saccharin Drugs 0.000 description 1
• 235000019204 saccharin Nutrition 0.000 description 1
• 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
• 229940085605 saccharin sodium Drugs 0.000 description 1
• 229960004889 salicylic acid Drugs 0.000 description 1
• 239000012488 sample solution Substances 0.000 description 1
• 230000036186 satiety Effects 0.000 description 1
• 235000019627 satiety Nutrition 0.000 description 1
• 150000004671 saturated fatty acids Chemical class 0.000 description 1
• 230000000580 secretagogue effect Effects 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 239000004208 shellac Substances 0.000 description 1
• 229940113147 shellac Drugs 0.000 description 1
• ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
• 235000013874 shellac Nutrition 0.000 description 1
• UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 description 1
• 229960004425 sibutramine Drugs 0.000 description 1
• 229960002855 simvastatin Drugs 0.000 description 1
• RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
• AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
• LLELVHKMCSBMCX-UHFFFAOYSA-M sodium 1-[(4-chloro-5-methyl-2-sulfophenyl)diazenyl]naphthalen-2-olate Chemical compound [Na+].Cc1cc(N=Nc2c(O)ccc3ccccc23)c(cc1Cl)S([O-])(=O)=O LLELVHKMCSBMCX-UHFFFAOYSA-M 0.000 description 1
• 239000001632 sodium acetate Substances 0.000 description 1
• 235000017281 sodium acetate Nutrition 0.000 description 1
• 229960004249 sodium acetate Drugs 0.000 description 1
• 235000010378 sodium ascorbate Nutrition 0.000 description 1
• PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
• 229960005055 sodium ascorbate Drugs 0.000 description 1
• WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
• 235000010234 sodium benzoate Nutrition 0.000 description 1
• 239000004299 sodium benzoate Substances 0.000 description 1
• 229960003885 sodium benzoate Drugs 0.000 description 1
• 229940001607 sodium bisulfite Drugs 0.000 description 1
• 229940001593 sodium carbonate Drugs 0.000 description 1
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• 229960001790 sodium citrate Drugs 0.000 description 1
• 229960000999 sodium citrate dihydrate Drugs 0.000 description 1
• 235000011083 sodium citrates Nutrition 0.000 description 1
• HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
• 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
• 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
• 229940001584 sodium metabisulfite Drugs 0.000 description 1
• 235000010262 sodium metabisulphite Nutrition 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 229960003339 sodium phosphate Drugs 0.000 description 1
• 159000000000 sodium salts Chemical class 0.000 description 1
• 229920003109 sodium starch glycolate Polymers 0.000 description 1
• 239000008109 sodium starch glycolate Substances 0.000 description 1
• 229940079832 sodium starch glycolate Drugs 0.000 description 1
• 235000010339 sodium tetraborate Nutrition 0.000 description 1
• PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
• 239000011343 solid material Substances 0.000 description 1
• 239000007892 solid unit dosage form Substances 0.000 description 1
• 239000011877 solvent mixture Substances 0.000 description 1
• 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
• 239000001570 sorbitan monopalmitate Substances 0.000 description 1
• 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
• 229960002920 sorbitol Drugs 0.000 description 1
• 239000003549 soybean oil Substances 0.000 description 1
• 235000012424 soybean oil Nutrition 0.000 description 1
• LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
• 229960002256 spironolactone Drugs 0.000 description 1
• 230000002269 spontaneous effect Effects 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 229960004274 stearic acid Drugs 0.000 description 1
• 239000008227 sterile water for injection Substances 0.000 description 1
• 239000008229 sterile water for irrigation Substances 0.000 description 1
• 235000003702 sterols Nutrition 0.000 description 1
• 239000003351 stiffener Substances 0.000 description 1
• 208000023516 stroke disease Diseases 0.000 description 1
• 229920003048 styrene butadiene rubber Polymers 0.000 description 1
• 238000006467 substitution reaction Methods 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 239000002511 suppository base Substances 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 238000013268 sustained release Methods 0.000 description 1
• 239000012730 sustained-release form Substances 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 229920003051 synthetic elastomer Polymers 0.000 description 1
• 239000005061 synthetic rubber Substances 0.000 description 1
• 239000002700 tablet coating Substances 0.000 description 1
• 238000009492 tablet coating Methods 0.000 description 1
• 239000007885 tablet disintegrant Substances 0.000 description 1
• 150000003505 terpenes Chemical class 0.000 description 1
• 235000007586 terpenes Nutrition 0.000 description 1
• FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 1
• WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
• WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
• 229940126585 therapeutic drug Drugs 0.000 description 1
• 230000001225 therapeutic effect Effects 0.000 description 1
• 150000001467 thiazolidinediones Chemical class 0.000 description 1
• 230000008719 thickening Effects 0.000 description 1
• 229950004437 tiqueside Drugs 0.000 description 1
• 239000004408 titanium dioxide Substances 0.000 description 1
• 229960005371 tolbutamide Drugs 0.000 description 1
• 125000003203 triacylglycerol group Chemical group 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
• 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
• BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
• HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
• 239000012588 trypsin Substances 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 238000000825 ultraviolet detection Methods 0.000 description 1
• ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 1
• 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
• 229960004699 valsartan Drugs 0.000 description 1
• SJSNUMAYCRRIOM-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SJSNUMAYCRRIOM-QFIPXVFZSA-N 0.000 description 1
• 235000012141 vanillin Nutrition 0.000 description 1
• MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
• FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
• 229960001722 verapamil Drugs 0.000 description 1
• 229960001729 voglibose Drugs 0.000 description 1
• 239000000341 volatile oil Substances 0.000 description 1
• 230000037221 weight management Effects 0.000 description 1
• 210000002268 wool Anatomy 0.000 description 1
• 229940002552 xenical Drugs 0.000 description 1
• 229960002769 zofenopril Drugs 0.000 description 1
• IAIDUHCBNLFXEF-MNEFBYGVSA-N zofenopril Chemical compound C([C@@H](C)C(=O)N1[C@@H](C[C@@H](C1)SC=1C=CC=CC=1)C(O)=O)SC(=O)C1=CC=CC=C1 IAIDUHCBNLFXEF-MNEFBYGVSA-N 0.000 description 1